| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glycosaminoglycan binding | SELP FBLN7 STAB2 AZU1 APOB ITGAM CEMIP CCN6 SLIT2 IGFALS ADAMTSL5 SLIT1 SLIT3 TENM1 CCL2 | 4.58e-11 | 268 | 116 | 15 | GO:0005539 |
| GeneOntologyMolecularFunction | heparin binding | SELP FBLN7 AZU1 APOB ITGAM CCN6 SLIT2 IGFALS ADAMTSL5 SLIT1 SLIT3 TENM1 CCL2 | 9.25e-11 | 192 | 116 | 13 | GO:0008201 |
| GeneOntologyMolecularFunction | calcium ion binding | SELP NID2 FBLN7 STAB2 LRP1B SVEP1 CRB1 JAG2 SLIT2 FBN2 JAG1 SLIT1 SLIT3 AOC3 LRP1 SCUBE3 LTBP1 PCDH1 FBN3 NOTCH1 NOTCH4 CRB2 | 3.15e-10 | 749 | 116 | 22 | GO:0005509 |
| GeneOntologyMolecularFunction | sulfur compound binding | SELP FBLN7 AZU1 APOB ITGAM CCN6 SLIT2 IGFALS ADAMTSL5 SLIT1 SLIT3 TENM1 LRP1 CCL2 | 5.82e-09 | 323 | 116 | 14 | GO:1901681 |
| GeneOntologyMolecularFunction | heparan sulfate proteoglycan binding | 1.44e-08 | 29 | 116 | 6 | GO:0043395 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 4.91e-07 | 51 | 116 | 6 | GO:0043394 | |
| GeneOntologyMolecularFunction | Roundabout binding | 5.16e-07 | 12 | 116 | 4 | GO:0048495 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 6.00e-06 | 21 | 116 | 4 | GO:0030228 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.42e-05 | 188 | 116 | 8 | GO:0005201 | |
| GeneOntologyMolecularFunction | Notch binding | 1.71e-05 | 27 | 116 | 4 | GO:0005112 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 1.01e-04 | 16 | 116 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.37e-04 | 85 | 116 | 5 | GO:0038024 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 1.37e-04 | 85 | 116 | 5 | GO:0019199 | |
| GeneOntologyMolecularFunction | microfibril binding | 4.94e-04 | 6 | 116 | 2 | GO:0050436 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 5.05e-04 | 27 | 116 | 3 | GO:0005044 | |
| GeneOntologyMolecularFunction | integrin binding | 5.57e-04 | 175 | 116 | 6 | GO:0005178 | |
| GeneOntologyMolecularFunction | structural molecule activity | NID2 VWF COL16A1 SSPOP SPTBN4 SLIT2 FBN2 MRPS2 JAG1 NPAP1 LTBP1 BSN FBN3 OTOG | 6.61e-04 | 891 | 116 | 14 | GO:0005198 |
| GeneOntologyMolecularFunction | molecular function inhibitor activity | CRIM1 SSPOP SLIT2 ZNF451 PKD1 LTBP1 BSN DKK4 RECK NOTCH1 CRB2 | 7.08e-04 | 596 | 116 | 11 | GO:0140678 |
| GeneOntologyMolecularFunction | coreceptor activity | 8.21e-04 | 72 | 116 | 4 | GO:0015026 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 8.64e-04 | 73 | 116 | 4 | GO:0050840 | |
| GeneOntologyMolecularFunction | Wnt-protein binding | 1.00e-03 | 34 | 116 | 3 | GO:0017147 | |
| GeneOntologyMolecularFunction | clathrin heavy chain binding | 2.13e-03 | 12 | 116 | 2 | GO:0032050 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 2.59e-03 | 599 | 116 | 10 | GO:0050839 | |
| GeneOntologyBiologicalProcess | chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration | 1.78e-07 | 3 | 117 | 3 | GO:0021834 | |
| GeneOntologyBiologicalProcess | embryonic olfactory bulb interneuron precursor migration | 1.76e-06 | 5 | 117 | 3 | GO:0021831 | |
| GeneOntologyBiologicalProcess | vasculature development | GPLD1 SCN11A ERBB2 STAB2 THSD7A GRN APOB SVEP1 STAT1 CCN6 SLIT2 JAG1 PKD1 LRP1 CCL2 LTBP1 RECK NOTCH1 NOTCH4 | 2.16e-06 | 969 | 117 | 19 | GO:0001944 |
| GeneOntologyBiologicalProcess | blood vessel development | GPLD1 SCN11A ERBB2 STAB2 THSD7A GRN APOB STAT1 CCN6 SLIT2 JAG1 PKD1 LRP1 CCL2 LTBP1 RECK NOTCH1 NOTCH4 | 4.87e-06 | 929 | 117 | 18 | GO:0001568 |
| GeneOntologyBiologicalProcess | artery development | 1.09e-05 | 133 | 117 | 7 | GO:0060840 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 1.14e-05 | 134 | 117 | 7 | GO:0003279 | |
| GeneOntologyBiologicalProcess | circulatory system development | GPLD1 SCN11A ERBB2 STAB2 THSD7A NSD2 GRN APOB SVEP1 STAT1 CCN6 SLIT2 JAG1 SLIT3 PKD1 LRP1 CCL2 LTBP1 RECK NOTCH1 NOTCH4 CRB2 | 1.78e-05 | 1442 | 117 | 22 | GO:0072359 |
| GeneOntologyBiologicalProcess | tangential migration from the subventricular zone to the olfactory bulb | 2.07e-05 | 10 | 117 | 3 | GO:0022028 | |
| GeneOntologyBiologicalProcess | olfactory bulb interneuron development | 2.84e-05 | 11 | 117 | 3 | GO:0021891 | |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 2.91e-05 | 63 | 117 | 5 | GO:0007157 | |
| GeneOntologyBiologicalProcess | positive regulation of protein targeting to membrane | 4.49e-05 | 35 | 117 | 4 | GO:0090314 | |
| GeneOntologyBiologicalProcess | negative regulation of epithelial cell differentiation | 4.53e-05 | 69 | 117 | 5 | GO:0030857 | |
| GeneOntologyBiologicalProcess | substrate-independent telencephalic tangential migration | 4.88e-05 | 13 | 117 | 3 | GO:0021826 | |
| GeneOntologyBiologicalProcess | substrate-independent telencephalic tangential interneuron migration | 4.88e-05 | 13 | 117 | 3 | GO:0021843 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | GPLD1 ERBB2 STAB2 THSD7A GRN APOB STAT1 CCN6 SLIT2 JAG1 LRP1 CCL2 RECK NOTCH1 NOTCH4 | 5.99e-05 | 817 | 117 | 15 | GO:0048514 |
| GeneOntologyBiologicalProcess | aortic valve morphogenesis | 6.94e-05 | 39 | 117 | 4 | GO:0003180 | |
| GeneOntologyBiologicalProcess | aorta morphogenesis | 8.47e-05 | 41 | 117 | 4 | GO:0035909 | |
| GeneOntologyBiologicalProcess | aorta development | 9.23e-05 | 80 | 117 | 5 | GO:0035904 | |
| GeneOntologyBiologicalProcess | complement receptor mediated signaling pathway | 9.44e-05 | 16 | 117 | 3 | GO:0002430 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to membrane | 9.86e-05 | 130 | 117 | 6 | GO:1905477 | |
| GeneOntologyBiologicalProcess | regulation of protein targeting to membrane | 1.02e-04 | 43 | 117 | 4 | GO:0090313 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 1.16e-04 | 410 | 117 | 10 | GO:0031589 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | SELP ERBB2 ZAN ITGAM IL23A SVEP1 CRB1 SLIT2 TENM3 JAG1 PKD1 TENM1 CCL2 PCDH1 NOTCH1 NOTCH4 CRB2 | 1.21e-04 | 1077 | 117 | 17 | GO:0098609 |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 1.21e-04 | 412 | 117 | 10 | GO:0090287 | |
| GeneOntologyBiologicalProcess | aortic valve development | 1.34e-04 | 46 | 117 | 4 | GO:0003176 | |
| GeneOntologyBiologicalProcess | cardiac septum morphogenesis | 1.53e-04 | 89 | 117 | 5 | GO:0060411 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 1.55e-04 | 270 | 117 | 8 | GO:0007160 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.63e-04 | 347 | 117 | 9 | GO:0090092 | |
| GeneOntologyBiologicalProcess | ventricular septum development | 1.70e-04 | 91 | 117 | 5 | GO:0003281 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 1.79e-04 | 92 | 117 | 5 | GO:0048844 | |
| GeneOntologyBiologicalProcess | semi-lunar valve development | 1.85e-04 | 50 | 117 | 4 | GO:1905314 | |
| GeneOntologyBiologicalProcess | pulmonary valve morphogenesis | 1.89e-04 | 20 | 117 | 3 | GO:0003184 | |
| GeneOntologyBiologicalProcess | positive regulation of aorta morphogenesis | 1.90e-04 | 4 | 117 | 2 | GO:1903849 | |
| GeneOntologyBiologicalProcess | astrocyte activation involved in immune response | 1.90e-04 | 4 | 117 | 2 | GO:0002265 | |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 1.90e-04 | 4 | 117 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | dorsal/ventral axon guidance | 1.90e-04 | 4 | 117 | 2 | GO:0033563 | |
| GeneOntologyBiologicalProcess | angiogenesis | GPLD1 ERBB2 STAB2 THSD7A GRN STAT1 CCN6 SLIT2 JAG1 CCL2 RECK NOTCH1 NOTCH4 | 1.92e-04 | 708 | 117 | 13 | GO:0001525 |
| GeneOntologyBiologicalProcess | negative chemotaxis | 2.00e-04 | 51 | 117 | 4 | GO:0050919 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | GPLD1 ERBB2 STAB2 THSD7A GRN APOB STAT1 CCN6 SLIT2 JAG1 PKD1 LRP1 CCL2 CSMD1 RECK NOTCH1 NOTCH4 | 2.03e-04 | 1125 | 117 | 17 | GO:0035239 |
| GeneOntologyBiologicalProcess | cardiac chamber development | 2.09e-04 | 212 | 117 | 7 | GO:0003205 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 2.25e-04 | 445 | 117 | 10 | GO:0141091 | |
| GeneOntologyBiologicalProcess | positive regulation of Notch signaling pathway | 2.32e-04 | 53 | 117 | 4 | GO:0045747 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | APOB ITGAM IL23A STAT1 BNC1 CCN6 SLIT2 FBN2 PTPRA JAG1 FRZB LRP1 SCUBE3 ZFHX3 NOTCH1 NOTCH4 CRB2 | 2.39e-04 | 1141 | 117 | 17 | GO:0045597 |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | SELP ERBB2 COL16A1 AZU1 IL23A JAG2 PTPRA TENM3 JAG1 PKD1 LRP1 CCL2 ZFHX3 NOTCH1 NOTCH4 | 2.40e-04 | 927 | 117 | 15 | GO:0030155 |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | GPLD1 ERBB2 STAB2 THSD7A GRN PRAMEF17 STAT1 CRB1 CCN6 SLIT2 FBN2 JAG1 PKD1 CCL2 CNOT1 DKK4 RECK NOTCH1 NOTCH4 CRB2 | 2.43e-04 | 1483 | 117 | 20 | GO:0048646 |
| GeneOntologyBiologicalProcess | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 2.48e-04 | 218 | 117 | 7 | GO:0090101 | |
| GeneOntologyBiologicalProcess | negative regulation of chemotaxis | 2.50e-04 | 54 | 117 | 4 | GO:0050922 | |
| GeneOntologyBiologicalProcess | axon extension involved in axon guidance | 2.53e-04 | 22 | 117 | 3 | GO:0048846 | |
| GeneOntologyBiologicalProcess | neuron projection extension involved in neuron projection guidance | 2.53e-04 | 22 | 117 | 3 | GO:1902284 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | PAPPA2 NSD2 STAT1 CRB1 JAG2 SLIT2 FBN2 OLFM3 TENM3 JAG1 FRZB SLIT1 SLIT3 PKD1 CCL2 CSMD1 NOTCH1 CRB2 | 2.82e-04 | 1269 | 117 | 18 | GO:0009887 |
| GeneOntologyBiologicalProcess | ventricular septum morphogenesis | 2.88e-04 | 56 | 117 | 4 | GO:0060412 | |
| GeneOntologyBiologicalProcess | positive regulation of locomotion | SELP GPLD1 AZU1 GRN IL23A CEMIP SLIT2 SCARB1 AOC3 IQSEC1 LRP1 CCL2 NOTCH1 | 3.02e-04 | 742 | 117 | 13 | GO:0040017 |
| GeneOntologyBiologicalProcess | cardiac ventricle development | 3.16e-04 | 161 | 117 | 6 | GO:0003231 | |
| GeneOntologyBiologicalProcess | pulmonary valve development | 3.30e-04 | 24 | 117 | 3 | GO:0003177 | |
| GeneOntologyBiologicalProcess | tube development | GPLD1 ERBB2 STAB2 THSD7A GRN APOB STAT1 CCN6 SLIT2 JAG1 PKD1 SCAPER LRP1 CCL2 PHF14 CSMD1 RECK NOTCH1 NOTCH4 | 3.34e-04 | 1402 | 117 | 19 | GO:0035295 |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | HJV GPLD1 ERBB2 CRIM1 IDE SVEP1 FBN2 PTPRA ZNF451 LRP1 SCUBE3 CCL2 PHF14 LTBP1 MUSK NOTCH1 CRB2 | 3.75e-04 | 1186 | 117 | 17 | GO:0007167 |
| GeneOntologyBiologicalProcess | cell junction organization | ERBB2 COL16A1 GRN CSMD2 ITGAM SVEP1 SPTBN4 SLIT2 PTPRA TENM3 SLIT1 IQSEC1 LRP1 BSN MUSK | 4.06e-04 | 974 | 117 | 15 | GO:0034330 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 4.19e-04 | 313 | 117 | 8 | GO:0098742 | |
| GeneOntologyBiologicalProcess | olfactory bulb interneuron differentiation | 4.20e-04 | 26 | 117 | 3 | GO:0021889 | |
| GeneOntologyBiologicalProcess | leukocyte migration involved in inflammatory response | 4.20e-04 | 26 | 117 | 3 | GO:0002523 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 4.24e-04 | 482 | 117 | 10 | GO:0007178 | |
| GeneOntologyBiologicalProcess | heart valve morphogenesis | 4.53e-04 | 63 | 117 | 4 | GO:0003179 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell fate commitment | 4.71e-04 | 6 | 117 | 2 | GO:0060120 | |
| GeneOntologyBiologicalProcess | regulation of aorta morphogenesis | 4.71e-04 | 6 | 117 | 2 | GO:1903847 | |
| GeneOntologyBiologicalProcess | auditory receptor cell fate commitment | 4.71e-04 | 6 | 117 | 2 | GO:0009912 | |
| GeneOntologyBiologicalProcess | inhibition of neuroepithelial cell differentiation | 4.71e-04 | 6 | 117 | 2 | GO:0002085 | |
| GeneOntologyBiologicalProcess | regulation of Notch signaling pathway | 4.84e-04 | 114 | 117 | 5 | GO:0008593 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription of Notch receptor target | 6.58e-04 | 7 | 117 | 2 | GO:0007221 | |
| GeneOntologyBiologicalProcess | Roundabout signaling pathway | 6.58e-04 | 7 | 117 | 2 | GO:0035385 | |
| GeneOntologyBiologicalProcess | chemotaxis | 7.29e-04 | 517 | 117 | 10 | GO:0006935 | |
| GeneOntologyBiologicalProcess | taxis | 7.51e-04 | 519 | 117 | 10 | GO:0042330 | |
| GeneOntologyBiologicalProcess | eye photoreceptor cell differentiation | 7.52e-04 | 72 | 117 | 4 | GO:0001754 | |
| GeneOntologyBiologicalProcess | gliogenesis | 8.43e-04 | 435 | 117 | 9 | GO:0042063 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in extracellular region | 8.74e-04 | 8 | 117 | 2 | GO:0071694 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance by cellular catabolic process | 8.74e-04 | 8 | 117 | 2 | GO:0150094 | |
| GeneOntologyBiologicalProcess | negative regulation of complement activation, classical pathway | 8.74e-04 | 8 | 117 | 2 | GO:0045959 | |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol storage | 8.74e-04 | 8 | 117 | 2 | GO:0010886 | |
| GeneOntologyBiologicalProcess | regulation of cell-substrate junction organization | 8.76e-04 | 75 | 117 | 4 | GO:0150116 | |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 9.09e-04 | 131 | 117 | 5 | GO:0030510 | |
| GeneOntologyBiologicalProcess | heart valve development | 1.02e-03 | 78 | 117 | 4 | GO:0003170 | |
| GeneOntologyBiologicalProcess | motor neuron axon guidance | 1.02e-03 | 35 | 117 | 3 | GO:0008045 | |
| GeneOntologyBiologicalProcess | eye morphogenesis | 1.09e-03 | 204 | 117 | 6 | GO:0048592 | |
| GeneOntologyBiologicalProcess | positive regulation of artery morphogenesis | 1.12e-03 | 9 | 117 | 2 | GO:1905653 | |
| GeneOntologyBiologicalProcess | positive regulation of cardiac epithelial to mesenchymal transition | 1.12e-03 | 9 | 117 | 2 | GO:0062043 | |
| GeneOntologyBiologicalProcess | axon guidance | 1.22e-03 | 285 | 117 | 7 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 1.24e-03 | 286 | 117 | 7 | GO:0097485 | |
| GeneOntologyBiologicalProcess | regulation of locomotion | SELP GPLD1 AZU1 GRN IL23A CEMIP SLIT2 FBN2 SCARB1 JAG1 SLIT1 AOC3 IQSEC1 LRP1 CCL2 RECK NOTCH1 | 1.31e-03 | 1327 | 117 | 17 | GO:0040012 |
| GeneOntologyBiologicalProcess | response to wounding | SELP ERBB2 VWF GRN SVEP1 BNC1 SCARB1 LRP1 CCL2 CYP4F11 NOTCH4 | 1.32e-03 | 659 | 117 | 11 | GO:0009611 |
| GeneOntologyBiologicalProcess | negative regulation of cell-cell adhesion mediated by cadherin | 1.39e-03 | 10 | 117 | 2 | GO:2000048 | |
| GeneOntologyBiologicalProcess | regulation of complement activation, classical pathway | 1.39e-03 | 10 | 117 | 2 | GO:0030450 | |
| GeneOntologyBiologicalProcess | negative regulation of metallopeptidase activity | 1.39e-03 | 10 | 117 | 2 | GO:1905049 | |
| GeneOntologyBiologicalProcess | negative regulation of chemokine-mediated signaling pathway | 1.39e-03 | 10 | 117 | 2 | GO:0070100 | |
| GeneOntologyBiologicalProcess | distal tubule development | 1.39e-03 | 10 | 117 | 2 | GO:0072017 | |
| GeneOntologyBiologicalProcess | cellular extravasation | 1.40e-03 | 85 | 117 | 4 | GO:0045123 | |
| GeneOntologyBiologicalProcess | neuron development | SCN11A ERBB2 GRN CRB1 SPTBN4 SLIT2 OLFM3 IGFALS TENM3 SLIT1 SLIT3 IQSEC1 TENM1 LRP1 MUSK NOTCH1 CRB2 OTOG | 1.48e-03 | 1463 | 117 | 18 | GO:0048666 |
| GeneOntologyBiologicalProcess | amyloid-beta clearance | 1.51e-03 | 40 | 117 | 3 | GO:0097242 | |
| GeneOntologyBiologicalProcess | maintenance of synapse structure | 1.51e-03 | 40 | 117 | 3 | GO:0099558 | |
| GeneOntologyBiologicalProcess | response to growth factor | HJV ERBB2 CRIM1 SLIT2 FBN2 ZNF451 LRP1 SCUBE3 CCL2 ZFHX3 LTBP1 NOTCH1 CRB2 | 1.51e-03 | 883 | 117 | 13 | GO:0070848 |
| GeneOntologyCellularComponent | extracellular matrix | GPLD1 NID2 FBLN7 LAMB4 VWF COL16A1 ZAN MUC5B SSPOP SVEP1 CCN6 SLIT2 FBN2 IGFALS ADAMTSL5 LTBP1 FBN3 OTOG | 3.32e-08 | 656 | 119 | 18 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | GPLD1 NID2 FBLN7 LAMB4 VWF COL16A1 ZAN MUC5B SSPOP SVEP1 CCN6 SLIT2 FBN2 IGFALS ADAMTSL5 LTBP1 FBN3 OTOG | 3.48e-08 | 658 | 119 | 18 | GO:0030312 |
| GeneOntologyCellularComponent | microfibril | 6.86e-07 | 13 | 119 | 4 | GO:0001527 | |
| GeneOntologyCellularComponent | cell surface | HJV SELP NID2 STAB2 VWF ADAM21 IDE ITGAM CR2 SLIT2 SCARB1 PKD1 AOC3 LRP1 SCUBE3 BSN MUSK NOTCH1 NOTCH4 | 1.63e-05 | 1111 | 119 | 19 | GO:0009986 |
| GeneOntologyCellularComponent | C-fiber | 1.91e-04 | 4 | 119 | 2 | GO:0044299 | |
| GeneOntologyCellularComponent | subapical complex | 3.18e-04 | 5 | 119 | 2 | GO:0035003 | |
| GeneOntologyCellularComponent | apical plasma membrane | 4.74e-04 | 487 | 119 | 10 | GO:0016324 | |
| GeneOntologyCellularComponent | receptor complex | HJV ERBB2 TRAF1 ITGAM CR2 LRP1B OLFM3 PTPRA LRP1 MUSK NOTCH1 | 4.88e-04 | 581 | 119 | 11 | GO:0043235 |
| GeneOntologyCellularComponent | apical part of cell | PAPPA2 ERBB2 SI TMEM235 CRB1 JAG1 LRP1 CYP4F11 NOTCH1 CRB2 OTOG | 5.70e-04 | 592 | 119 | 11 | GO:0045177 |
| GeneOntologyCellularComponent | side of membrane | HJV SELP TRAF1 STAB2 VWF RASA3 ADAM21 IDE ITGAM CR2 LRP1 MUSK RECK | 1.44e-03 | 875 | 119 | 13 | GO:0098552 |
| Domain | EGF_3 | SELP NID2 FBLN7 STAB2 ZAN ADAM21 SSPOP LRP1B SVEP1 CRB1 MEP1A JAG2 SLIT2 FBN2 TENM3 JAG1 SLIT1 SLIT3 TENM1 LRP1 SCUBE3 LTBP1 FBN3 NOTCH1 NOTCH4 CRB2 OTOG | 1.26e-26 | 235 | 118 | 27 | PS50026 |
| Domain | EGF_2 | SELP NID2 FBLN7 LAMB4 STAB2 ZAN ADAM21 SSPOP LRP1B SVEP1 CRB1 MEP1A JAG2 SLIT2 FBN2 TENM3 JAG1 SLIT1 SLIT3 TENM1 LRP1 SCUBE3 LTBP1 FBN3 NOTCH1 NOTCH4 CRB2 | 3.37e-25 | 265 | 118 | 27 | PS01186 |
| Domain | EGF-like_dom | SELP NID2 FBLN7 STAB2 ZAN ADAM21 LRP1B SVEP1 CRB1 MEP1A JAG2 SLIT2 FBN2 TENM3 JAG1 SLIT1 SLIT3 TENM1 LRP1 SCUBE3 LTBP1 FBN3 NOTCH1 NOTCH4 CRB2 OTOG | 1.49e-24 | 249 | 118 | 26 | IPR000742 |
| Domain | EGF | SELP NID2 FBLN7 STAB2 ZAN LRP1B SVEP1 CRB1 MEP1A JAG2 SLIT2 JAG1 SLIT1 SLIT3 LRP1 SCUBE3 LTBP1 FBN3 NOTCH1 NOTCH4 CRB2 | 2.51e-24 | 126 | 118 | 21 | PF00008 |
| Domain | EGF_1 | SELP FBLN7 LAMB4 STAB2 ZAN ADAM21 SSPOP LRP1B SVEP1 CRB1 MEP1A JAG2 SLIT2 FBN2 TENM3 JAG1 SLIT1 SLIT3 TENM1 LRP1 SCUBE3 LTBP1 FBN3 NOTCH1 NOTCH4 CRB2 | 2.79e-24 | 255 | 118 | 26 | PS00022 |
| Domain | EGF-like_CS | SELP NID2 FBLN7 LAMB4 STAB2 ZAN ADAM21 LRP1B SVEP1 CRB1 MEP1A JAG2 SLIT2 FBN2 TENM3 JAG1 SLIT1 SLIT3 TENM1 LRP1 SCUBE3 LTBP1 FBN3 NOTCH1 NOTCH4 CRB2 | 5.11e-24 | 261 | 118 | 26 | IPR013032 |
| Domain | EGF | SELP NID2 FBLN7 STAB2 ZAN LRP1B SVEP1 CRB1 MEP1A JAG2 SLIT2 FBN2 TENM3 JAG1 SLIT1 SLIT3 TENM1 LRP1 SCUBE3 LTBP1 FBN3 NOTCH1 NOTCH4 CRB2 | 1.85e-22 | 235 | 118 | 24 | SM00181 |
| Domain | EGF_Ca-bd_CS | NID2 FBLN7 LRP1B SVEP1 CRB1 JAG2 SLIT2 FBN2 JAG1 SLIT1 SLIT3 LRP1 SCUBE3 LTBP1 FBN3 NOTCH1 NOTCH4 CRB2 | 7.43e-22 | 97 | 118 | 18 | IPR018097 |
| Domain | EGF_CA | NID2 FBLN7 LRP1B SVEP1 CRB1 JAG2 SLIT2 FBN2 JAG1 SLIT1 SLIT3 LRP1 SCUBE3 LTBP1 FBN3 NOTCH1 NOTCH4 CRB2 | 1.10e-21 | 99 | 118 | 18 | PS01187 |
| Domain | EGF_CA | NID2 FBLN7 STAB2 LRP1B SVEP1 CRB1 JAG2 SLIT2 FBN2 JAG1 SLIT1 SLIT3 LRP1 SCUBE3 LTBP1 FBN3 NOTCH1 NOTCH4 CRB2 | 1.73e-21 | 122 | 118 | 19 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | NID2 FBLN7 STAB2 LRP1B SVEP1 CRB1 JAG2 SLIT2 FBN2 JAG1 SLIT1 SLIT3 LRP1 SCUBE3 LTBP1 FBN3 NOTCH1 NOTCH4 CRB2 | 2.39e-21 | 124 | 118 | 19 | IPR001881 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | NID2 FBLN7 LRP1B SVEP1 CRB1 JAG2 SLIT2 FBN2 JAG1 SLIT1 SLIT3 LRP1 SCUBE3 LTBP1 FBN3 NOTCH1 NOTCH4 CRB2 | 4.08e-21 | 106 | 118 | 18 | IPR000152 |
| Domain | Growth_fac_rcpt_ | NID2 ERBB2 STAB2 CRIM1 LRP1B SVEP1 CRB1 JAG2 CCN6 FBN2 JAG1 SLIT1 SLIT3 LRP1 SCUBE3 LTBP1 FBN3 NOTCH1 NOTCH4 | 2.17e-19 | 156 | 118 | 19 | IPR009030 |
| Domain | ASX_HYDROXYL | NID2 FBLN7 LRP1B SVEP1 CRB1 JAG2 SLIT2 FBN2 JAG1 LRP1 SCUBE3 LTBP1 FBN3 NOTCH1 NOTCH4 CRB2 | 1.95e-18 | 100 | 118 | 16 | PS00010 |
| Domain | hEGF | SVEP1 CRB1 JAG2 SLIT2 FBN2 JAG1 SLIT1 FBN3 NOTCH1 NOTCH4 CRB2 | 7.80e-18 | 28 | 118 | 11 | PF12661 |
| Domain | EGF_CA | NID2 FBLN7 LRP1B SVEP1 JAG2 FBN2 JAG1 LRP1 SCUBE3 LTBP1 FBN3 NOTCH1 NOTCH4 | 7.67e-15 | 86 | 118 | 13 | PF07645 |
| Domain | VWC_out | 1.42e-13 | 19 | 118 | 8 | SM00215 | |
| Domain | Cys_knot_C | 1.97e-12 | 25 | 118 | 8 | IPR006207 | |
| Domain | CTCK_2 | 1.97e-12 | 25 | 118 | 8 | PS01225 | |
| Domain | CTCK_1 | 1.01e-11 | 18 | 118 | 7 | PS01185 | |
| Domain | CT | 5.29e-11 | 22 | 118 | 7 | SM00041 | |
| Domain | VWF_dom | 1.97e-10 | 42 | 118 | 8 | IPR001007 | |
| Domain | cEGF | 2.00e-10 | 26 | 118 | 7 | PF12662 | |
| Domain | cEGF | 2.00e-10 | 26 | 118 | 7 | IPR026823 | |
| Domain | VWC | 3.60e-09 | 38 | 118 | 7 | SM00214 | |
| Domain | EGF_extracell | 3.89e-09 | 60 | 118 | 8 | IPR013111 | |
| Domain | EGF_2 | 3.89e-09 | 60 | 118 | 8 | PF07974 | |
| Domain | C8 | 7.07e-09 | 12 | 118 | 5 | PF08742 | |
| Domain | TIL | 7.07e-09 | 12 | 118 | 5 | PF01826 | |
| Domain | Unchr_dom_Cys-rich | 1.14e-08 | 13 | 118 | 5 | IPR014853 | |
| Domain | C8 | 1.14e-08 | 13 | 118 | 5 | SM00832 | |
| Domain | TIL_dom | 1.77e-08 | 14 | 118 | 5 | IPR002919 | |
| Domain | Sushi | 3.55e-08 | 52 | 118 | 7 | PF00084 | |
| Domain | VWF_type-D | 3.82e-08 | 16 | 118 | 5 | IPR001846 | |
| Domain | VWFD | 3.82e-08 | 16 | 118 | 5 | PS51233 | |
| Domain | VWD | 3.82e-08 | 16 | 118 | 5 | SM00216 | |
| Domain | VWD | 3.82e-08 | 16 | 118 | 5 | PF00094 | |
| Domain | CCP | 4.65e-08 | 54 | 118 | 7 | SM00032 | |
| Domain | SUSHI | 6.03e-08 | 56 | 118 | 7 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 6.84e-08 | 57 | 118 | 7 | IPR000436 | |
| Domain | VWFC_1 | 9.34e-08 | 36 | 118 | 6 | PS01208 | |
| Domain | VWFC_2 | 1.31e-07 | 38 | 118 | 6 | PS50184 | |
| Domain | ConA-like_dom | PAPPA2 TMPRSS15 COL16A1 ZAN SVEP1 CRB1 MEP1A SLIT2 SLIT1 SLIT3 CRB2 | 1.43e-07 | 219 | 118 | 11 | IPR013320 |
| Domain | - | 1.54e-07 | 95 | 118 | 8 | 2.60.120.200 | |
| Domain | Laminin_G | 1.73e-06 | 58 | 118 | 6 | IPR001791 | |
| Domain | YD | 2.44e-06 | 5 | 118 | 3 | IPR006530 | |
| Domain | LAM_G_DOMAIN | 3.93e-06 | 38 | 118 | 5 | PS50025 | |
| Domain | - | 4.48e-06 | 39 | 118 | 5 | 2.120.10.30 | |
| Domain | Laminin_G_2 | 5.10e-06 | 40 | 118 | 5 | PF02210 | |
| Domain | LamG | 8.24e-06 | 44 | 118 | 5 | SM00282 | |
| Domain | TB | 8.45e-06 | 7 | 118 | 3 | PF00683 | |
| Domain | Notch_dom | 8.45e-06 | 7 | 118 | 3 | IPR000800 | |
| Domain | Notch | 8.45e-06 | 7 | 118 | 3 | PF00066 | |
| Domain | NL | 8.45e-06 | 7 | 118 | 3 | SM00004 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.03e-05 | 46 | 118 | 5 | IPR011042 | |
| Domain | LDLRA_1 | 1.27e-05 | 48 | 118 | 5 | PS01209 | |
| Domain | - | 1.35e-05 | 8 | 118 | 3 | 3.90.290.10 | |
| Domain | LDLRA_2 | 1.41e-05 | 49 | 118 | 5 | PS50068 | |
| Domain | TB_dom | 2.01e-05 | 9 | 118 | 3 | IPR017878 | |
| Domain | TB | 2.01e-05 | 9 | 118 | 3 | PS51364 | |
| Domain | LRRNT | 2.08e-05 | 53 | 118 | 5 | PF01462 | |
| Domain | GFP-like | 3.91e-05 | 11 | 118 | 3 | IPR023413 | |
| Domain | - | 3.91e-05 | 11 | 118 | 3 | 2.40.155.10 | |
| Domain | DUF5050 | 3.96e-05 | 2 | 118 | 2 | IPR032485 | |
| Domain | DUF5050 | 3.96e-05 | 2 | 118 | 2 | PF16472 | |
| Domain | Jagged/Serrate | 3.96e-05 | 2 | 118 | 2 | IPR026219 | |
| Domain | EGF_dom | 5.19e-05 | 12 | 118 | 3 | IPR024731 | |
| Domain | EGF_3 | 5.19e-05 | 12 | 118 | 3 | PF12947 | |
| Domain | Ldl_recept_b | 8.51e-05 | 14 | 118 | 3 | PF00058 | |
| Domain | LDLRB | 8.51e-05 | 14 | 118 | 3 | PS51120 | |
| Domain | LY | 1.06e-04 | 15 | 118 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 1.06e-04 | 15 | 118 | 3 | IPR000033 | |
| Domain | LDLR_class-A_CS | 1.16e-04 | 40 | 118 | 4 | IPR023415 | |
| Domain | FBN | 1.18e-04 | 3 | 118 | 2 | IPR011398 | |
| Domain | MAM_1 | 1.30e-04 | 16 | 118 | 3 | PS00740 | |
| Domain | MAM | 1.57e-04 | 17 | 118 | 3 | SM00137 | |
| Domain | Ldl_recept_a | 1.85e-04 | 45 | 118 | 4 | PF00057 | |
| Domain | MAM | 1.87e-04 | 18 | 118 | 3 | PF00629 | |
| Domain | MAM_dom | 1.87e-04 | 18 | 118 | 3 | IPR000998 | |
| Domain | MAM_2 | 1.87e-04 | 18 | 118 | 3 | PS50060 | |
| Domain | - | 2.01e-04 | 46 | 118 | 4 | 4.10.400.10 | |
| Domain | Tox-GHH_dom | 2.36e-04 | 4 | 118 | 2 | IPR028916 | |
| Domain | Notch | 2.36e-04 | 4 | 118 | 2 | IPR008297 | |
| Domain | NODP | 2.36e-04 | 4 | 118 | 2 | PF07684 | |
| Domain | Notch_NODP_dom | 2.36e-04 | 4 | 118 | 2 | IPR011656 | |
| Domain | Tox-GHH | 2.36e-04 | 4 | 118 | 2 | PF15636 | |
| Domain | Ten_N | 2.36e-04 | 4 | 118 | 2 | IPR009471 | |
| Domain | Ten_N | 2.36e-04 | 4 | 118 | 2 | PF06484 | |
| Domain | DSL | 2.36e-04 | 4 | 118 | 2 | PF01414 | |
| Domain | Notch_NOD_dom | 2.36e-04 | 4 | 118 | 2 | IPR010660 | |
| Domain | TENEURIN_N | 2.36e-04 | 4 | 118 | 2 | PS51361 | |
| Domain | NOD | 2.36e-04 | 4 | 118 | 2 | PF06816 | |
| Domain | DSL | 2.36e-04 | 4 | 118 | 2 | SM00051 | |
| Domain | NOD | 2.36e-04 | 4 | 118 | 2 | SM01338 | |
| Domain | NODP | 2.36e-04 | 4 | 118 | 2 | SM01339 | |
| Domain | CUB | 2.58e-04 | 49 | 118 | 4 | PF00431 | |
| Domain | LDrepeatLR_classA_rpt | 2.58e-04 | 49 | 118 | 4 | IPR002172 | |
| Domain | LDLa | 2.58e-04 | 49 | 118 | 4 | SM00192 | |
| Domain | Cys-rich_flank_reg_C | 2.65e-04 | 90 | 118 | 5 | IPR000483 | |
| Domain | LRRCT | 2.65e-04 | 90 | 118 | 5 | SM00082 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 3.70e-08 | 16 | 89 | 5 | M47424 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 1.02e-06 | 13 | 89 | 4 | M47423 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 4.27e-06 | 68 | 89 | 6 | M27303 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 8.36e-06 | 7 | 89 | 3 | M27199 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 2.33e-05 | 27 | 89 | 4 | M39545 | |
| Pathway | REACTOME_REGULATION_OF_COMMISSURAL_AXON_PATHFINDING_BY_SLIT_AND_ROBO | 2.83e-05 | 10 | 89 | 3 | M27348 | |
| Pathway | PID_NOTCH_PATHWAY | 3.43e-05 | 59 | 89 | 5 | M17 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 5.14e-05 | 12 | 89 | 3 | M47532 | |
| Pathway | WP_SPINAL_CORD_INJURY | 6.10e-05 | 108 | 89 | 6 | MM15954 | |
| Pathway | WP_SPINAL_CORD_INJURY | 9.53e-05 | 117 | 89 | 6 | M39341 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 1.03e-04 | 39 | 89 | 4 | MM14604 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 1.05e-04 | 15 | 89 | 3 | M27202 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.14e-04 | 300 | 89 | 9 | M610 | |
| Pathway | PID_AMB2_NEUTROPHILS_PATHWAY | 1.26e-04 | 41 | 89 | 4 | M159 | |
| Pathway | WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION | 1.55e-04 | 17 | 89 | 3 | M39389 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 1.66e-04 | 44 | 89 | 4 | M875 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 1.81e-04 | 45 | 89 | 4 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 1.98e-04 | 46 | 89 | 4 | MM15971 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 2.15e-04 | 47 | 89 | 4 | M7946 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 2.53e-04 | 49 | 89 | 4 | M618 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 2.86e-04 | 143 | 89 | 6 | M27275 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 3.89e-04 | 5 | 89 | 2 | M27411 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 3.89e-04 | 5 | 89 | 2 | MM14733 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 5.06e-04 | 25 | 89 | 3 | M39713 | |
| Pathway | WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY | 5.50e-04 | 106 | 89 | 5 | M42535 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 5.53e-04 | 60 | 89 | 4 | MM14872 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_B_RECEPTORS | 5.82e-04 | 6 | 89 | 2 | M27220 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 5.82e-04 | 6 | 89 | 2 | M27068 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 5.89e-04 | 61 | 89 | 4 | M39540 | |
| Pathway | KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_EGF_JAK_STAT_SIGNALING_PATHWAY | 8.11e-04 | 7 | 89 | 2 | M47431 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 8.11e-04 | 7 | 89 | 2 | MM14734 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 8.95e-04 | 118 | 89 | 5 | M39852 | |
| Pathway | WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION | 9.62e-04 | 31 | 89 | 3 | M39514 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 9.62e-04 | 31 | 89 | 3 | M592 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 1.02e-03 | 250 | 89 | 7 | M27554 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.22e-03 | 258 | 89 | 7 | MM14572 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_LIGAND_UBIQUITYLATION | 1.38e-03 | 9 | 89 | 2 | M47866 | |
| Pathway | WP_NEOVASCULARIZATION_PROCESSES | 1.62e-03 | 37 | 89 | 3 | M39506 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.62e-03 | 37 | 89 | 3 | M27134 | |
| Pathway | PID_IL23_PATHWAY | 1.62e-03 | 37 | 89 | 3 | M196 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 1.72e-03 | 10 | 89 | 2 | MM14849 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 1.78e-03 | 82 | 89 | 4 | MM15922 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.89e-03 | 39 | 89 | 3 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.89e-03 | 39 | 89 | 3 | MM15165 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 2.09e-03 | 11 | 89 | 2 | M47865 | |
| Pathway | BIOCARTA_MONOCYTE_PATHWAY | 2.09e-03 | 11 | 89 | 2 | MM1436 | |
| Pathway | REACTOME_NOTCH4_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 2.09e-03 | 11 | 89 | 2 | M27882 | |
| Pathway | BIOCARTA_MONOCYTE_PATHWAY | 2.09e-03 | 11 | 89 | 2 | M4956 | |
| Pubmed | Evolution of Cortical Neurogenesis in Amniotes Controlled by Robo Signaling Levels. | 5.26e-11 | 20 | 119 | 6 | 29961574 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 2.29e-09 | 101 | 119 | 8 | 23382219 | |
| Pubmed | 4.52e-09 | 7 | 119 | 4 | 10079256 | ||
| Pubmed | The distribution of Notch receptors and their ligands during articular cartilage development. | 4.52e-09 | 7 | 119 | 4 | 12846471 | |
| Pubmed | 4.82e-09 | 19 | 119 | 5 | 25691540 | ||
| Pubmed | 7.91e-09 | 118 | 119 | 8 | 21078624 | ||
| Pubmed | 9.02e-09 | 8 | 119 | 4 | 9858718 | ||
| Pubmed | Divergent vascular mechanisms downstream of Sry establish the arterial system in the XY gonad. | 1.62e-08 | 9 | 119 | 4 | 11944948 | |
| Pubmed | 1.62e-08 | 9 | 119 | 4 | 11118901 | ||
| Pubmed | 1.62e-08 | 9 | 119 | 4 | 16245338 | ||
| Pubmed | Notch signaling is essential for vascular morphogenesis in mice. | 1.62e-08 | 9 | 119 | 4 | 10837027 | |
| Pubmed | PAPPA2 NID2 FLNB VWF THSD7A GRN SVEP1 HIPK3 FBN2 TENM3 ZNF451 PKD1 LRP1 PCDH1 | 1.66e-08 | 591 | 119 | 14 | 15231748 | |
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 2.69e-08 | 10 | 119 | 4 | 23665443 | |
| Pubmed | 3.91e-08 | 3 | 119 | 3 | 9813312 | ||
| Pubmed | 3.91e-08 | 3 | 119 | 3 | 14988227 | ||
| Pubmed | Inhibition of HER2 Increases JAGGED1-dependent Breast Cancer Stem Cells: Role for Membrane JAGGED1. | 3.91e-08 | 3 | 119 | 3 | 29895705 | |
| Pubmed | Intraislet SLIT-ROBO signaling is required for beta-cell survival and potentiates insulin secretion. | 3.91e-08 | 3 | 119 | 3 | 24065825 | |
| Pubmed | Slit-mediated repulsion is a key regulator of motor axon pathfinding in the hindbrain. | 3.91e-08 | 3 | 119 | 3 | 16162649 | |
| Pubmed | 3.91e-08 | 3 | 119 | 3 | 15939383 | ||
| Pubmed | 3.91e-08 | 3 | 119 | 3 | 16840550 | ||
| Pubmed | 3.91e-08 | 3 | 119 | 3 | 26341090 | ||
| Pubmed | Conserved modularity and potential for alternate splicing in mouse and human Slit genes. | 3.91e-08 | 3 | 119 | 3 | 12141424 | |
| Pubmed | 4.22e-08 | 11 | 119 | 4 | 10878608 | ||
| Pubmed | 4.22e-08 | 11 | 119 | 4 | 12866128 | ||
| Pubmed | 6.31e-08 | 12 | 119 | 4 | 15465494 | ||
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 9.10e-08 | 13 | 119 | 4 | 11578869 | |
| Pubmed | Inhibition of notch1-dependent cardiomyogenesis leads to a dilated myopathy in the neonatal heart. | 9.10e-08 | 13 | 119 | 4 | 20558824 | |
| Pubmed | 1.27e-07 | 14 | 119 | 4 | 18528438 | ||
| Pubmed | 1.27e-07 | 14 | 119 | 4 | 28192800 | ||
| Pubmed | Endothelial Jarid2/Jumonji is required for normal cardiac development and proper Notch1 expression. | 1.27e-07 | 14 | 119 | 4 | 21402699 | |
| Pubmed | 1.27e-07 | 14 | 119 | 4 | 14757642 | ||
| Pubmed | Slits contribute to the guidance of retinal ganglion cell axons in the mammalian optic tract. | 1.56e-07 | 4 | 119 | 3 | 16828733 | |
| Pubmed | 1.56e-07 | 4 | 119 | 3 | 36376768 | ||
| Pubmed | 1.56e-07 | 4 | 119 | 3 | 24398584 | ||
| Pubmed | 1.56e-07 | 4 | 119 | 3 | 10433822 | ||
| Pubmed | Detection of Notch signaling molecules in cemento-ossifying fibroma of the jaws. | 1.56e-07 | 4 | 119 | 3 | 20040020 | |
| Pubmed | 1.56e-07 | 4 | 119 | 3 | 10837254 | ||
| Pubmed | 1.56e-07 | 4 | 119 | 3 | 17984306 | ||
| Pubmed | 1.56e-07 | 4 | 119 | 3 | 9858728 | ||
| Pubmed | 1.56e-07 | 4 | 119 | 3 | 9315665 | ||
| Pubmed | 1.56e-07 | 4 | 119 | 3 | 20819128 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | FLNB ERBB2 RASA3 NSD2 IDE SSPOP HIPK3 JAG2 SPTBN4 SCARB1 SPACA6 LRP1 EHMT1 PHF14 ZFHX3 CSMD1 PCDH1 CYP4F11 CNOT1 RECK | 1.62e-07 | 1489 | 119 | 20 | 28611215 |
| Pubmed | 1.69e-07 | 71 | 119 | 6 | 33541421 | ||
| Pubmed | 1.73e-07 | 15 | 119 | 4 | 12971992 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 2.02e-07 | 248 | 119 | 9 | 24006456 | |
| Pubmed | 2.30e-07 | 16 | 119 | 4 | 17273555 | ||
| Pubmed | 2.30e-07 | 16 | 119 | 4 | 10842072 | ||
| Pubmed | Expression of Notch pathway components in fetal and adult mouse small intestine. | 2.30e-07 | 16 | 119 | 4 | 12617809 | |
| Pubmed | 2.93e-07 | 41 | 119 | 5 | 22675208 | ||
| Pubmed | 3.00e-07 | 17 | 119 | 4 | 18694942 | ||
| Pubmed | Segmental expression of Notch and Hairy genes in nephrogenesis. | 3.00e-07 | 17 | 119 | 4 | 15821257 | |
| Pubmed | 3.84e-07 | 18 | 119 | 4 | 15689374 | ||
| Pubmed | 3.84e-07 | 18 | 119 | 4 | 18093989 | ||
| Pubmed | On the topographic targeting of basal vomeronasal axons through Slit-mediated chemorepulsion. | 3.89e-07 | 5 | 119 | 3 | 12954717 | |
| Pubmed | 3.89e-07 | 5 | 119 | 3 | 28234971 | ||
| Pubmed | 3.89e-07 | 5 | 119 | 3 | 12175503 | ||
| Pubmed | Slit proteins are not dominant chemorepellents for olfactory tract and spinal motor axons. | 3.89e-07 | 5 | 119 | 3 | 11748139 | |
| Pubmed | 3.89e-07 | 5 | 119 | 3 | 12609596 | ||
| Pubmed | Physical interaction of Delta1, Jagged1, and Jagged2 with Notch1 and Notch3 receptors. | 3.89e-07 | 5 | 119 | 3 | 11006133 | |
| Pubmed | 3.89e-07 | 5 | 119 | 3 | 21602525 | ||
| Pubmed | Extracellular Ig domains 1 and 2 of Robo are important for ligand (Slit) binding. | 3.89e-07 | 5 | 119 | 3 | 15207848 | |
| Pubmed | 3.89e-07 | 5 | 119 | 3 | 11520671 | ||
| Pubmed | 3.89e-07 | 5 | 119 | 3 | 27118257 | ||
| Pubmed | 3.89e-07 | 5 | 119 | 3 | 20554499 | ||
| Pubmed | Functional diversity of notch family genes in fetal lung development. | 3.89e-07 | 5 | 119 | 3 | 15064243 | |
| Pubmed | 3.89e-07 | 5 | 119 | 3 | 15882997 | ||
| Pubmed | 4.85e-07 | 19 | 119 | 4 | 16518823 | ||
| Pubmed | Conversion of biliary system to pancreatic tissue in Hes1-deficient mice. | 7.45e-07 | 21 | 119 | 4 | 14702043 | |
| Pubmed | 7.45e-07 | 21 | 119 | 4 | 28656980 | ||
| Pubmed | 7.75e-07 | 6 | 119 | 3 | 10958687 | ||
| Pubmed | Characterization of Notch receptor expression in the developing mammalian heart and liver. | 7.75e-07 | 6 | 119 | 3 | 12244553 | |
| Pubmed | Slit/Robo-mediated chemorepulsion of vagal sensory axons in the fetal gut. | 7.75e-07 | 6 | 119 | 3 | 23161783 | |
| Pubmed | 7.75e-07 | 6 | 119 | 3 | 16439476 | ||
| Pubmed | Robo2 Receptor Gates the Anatomical Divergence of Neurons Derived From a Common Precursor Origin. | 7.75e-07 | 6 | 119 | 3 | 34249921 | |
| Pubmed | 7.75e-07 | 6 | 119 | 3 | 17822320 | ||
| Pubmed | Notch4 reveals a novel mechanism regulating Notch signal transduction. | 7.75e-07 | 6 | 119 | 3 | 24667410 | |
| Pubmed | 7.75e-07 | 6 | 119 | 3 | 10864954 | ||
| Pubmed | Autocrine/juxtaparacrine regulation of axon fasciculation by Slit-Robo signaling. | 7.75e-07 | 6 | 119 | 3 | 22306607 | |
| Pubmed | Pioneer longitudinal axons navigate using floor plate and Slit/Robo signals. | 7.75e-07 | 6 | 119 | 3 | 18842816 | |
| Pubmed | SLITs suppress tumor growth in vivo by silencing Sdf1/Cxcr4 within breast epithelium. | 7.75e-07 | 6 | 119 | 3 | 18829537 | |
| Pubmed | 8.56e-07 | 383 | 119 | 10 | 19453261 | ||
| Pubmed | 1.10e-06 | 23 | 119 | 4 | 14701881 | ||
| Pubmed | Rbpj regulates development of prosensory cells in the mammalian inner ear. | 1.31e-06 | 24 | 119 | 4 | 21420948 | |
| Pubmed | 1.31e-06 | 24 | 119 | 4 | 21633169 | ||
| Pubmed | 1.35e-06 | 7 | 119 | 3 | 10383933 | ||
| Pubmed | Evidence for a Notch1-mediated transition during olfactory ensheathing cell development. | 1.35e-06 | 7 | 119 | 3 | 27271278 | |
| Pubmed | Slit molecules prevent entrance of trunk neural crest cells in developing gut. | 1.35e-06 | 7 | 119 | 3 | 25490618 | |
| Pubmed | 1.35e-06 | 7 | 119 | 3 | 21688288 | ||
| Pubmed | 1.35e-06 | 7 | 119 | 3 | 20606719 | ||
| Pubmed | Notch signaling controls liver development by regulating biliary differentiation. | 1.84e-06 | 26 | 119 | 4 | 19369401 | |
| Pubmed | 1.86e-06 | 59 | 119 | 5 | 21421844 | ||
| Pubmed | Multiple Slits regulate the development of midline glial populations and the corpus callosum. | 2.16e-06 | 8 | 119 | 3 | 22349628 | |
| Pubmed | 2.16e-06 | 8 | 119 | 3 | 18245384 | ||
| Pubmed | Notch1 and Jagged1 expression by the developing pulmonary vasculature. | 2.16e-06 | 8 | 119 | 3 | 12242716 | |
| Pubmed | 2.16e-06 | 8 | 119 | 3 | 30936549 | ||
| Pubmed | 2.16e-06 | 8 | 119 | 3 | 23884932 | ||
| Pubmed | 2.16e-06 | 8 | 119 | 3 | 8562500 | ||
| Pubmed | P4 down-regulates Jagged2 and Notch1 expression during primordial folliculogenesis. | 2.16e-06 | 8 | 119 | 3 | 22652674 | |
| Pubmed | PlexinA1 is a new Slit receptor and mediates axon guidance function of Slit C-terminal fragments. | 2.16e-06 | 8 | 119 | 3 | 25485759 | |
| Pubmed | 2.16e-06 | 8 | 119 | 3 | 11044610 | ||
| Interaction | CACNA1A interactions | 3.31e-08 | 123 | 114 | 9 | int:CACNA1A | |
| Interaction | NTN5 interactions | 2.07e-07 | 24 | 114 | 5 | int:NTN5 | |
| Interaction | FBXO2 interactions | NID2 AZU1 GRN LRP1B CEMIP JAG2 SLIT2 FBN2 TENM3 SCARB1 JAG1 NOTCH1 | 3.74e-06 | 411 | 114 | 12 | int:FBXO2 |
| Interaction | IGFL3 interactions | 4.21e-06 | 75 | 114 | 6 | int:IGFL3 | |
| Interaction | MBD1 interactions | 4.91e-06 | 77 | 114 | 6 | int:MBD1 | |
| Interaction | MFAP5 interactions | 1.11e-05 | 52 | 114 | 5 | int:MFAP5 | |
| Interaction | GP1BA interactions | 1.54e-05 | 27 | 114 | 4 | int:GP1BA | |
| Interaction | ZFP41 interactions | 1.76e-05 | 57 | 114 | 5 | int:ZFP41 | |
| Interaction | DKK4 interactions | 2.06e-05 | 10 | 114 | 3 | int:DKK4 | |
| Interaction | HOXA1 interactions | 3.49e-05 | 356 | 114 | 10 | int:HOXA1 | |
| Interaction | MFAP2 interactions | 3.74e-05 | 12 | 114 | 3 | int:MFAP2 | |
| Interaction | NOTCH3 interactions | 4.43e-05 | 113 | 114 | 6 | int:NOTCH3 | |
| Interaction | ZDHHC15 interactions | 7.79e-05 | 125 | 114 | 6 | int:ZDHHC15 | |
| Interaction | GFI1B interactions | 1.24e-04 | 136 | 114 | 6 | int:GFI1B | |
| Interaction | NOTCH2 interactions | 1.46e-04 | 423 | 114 | 10 | int:NOTCH2 | |
| Interaction | WNT3A interactions | 1.69e-04 | 49 | 114 | 4 | int:WNT3A | |
| Interaction | PATE1 interactions | 1.69e-04 | 49 | 114 | 4 | int:PATE1 | |
| Interaction | MAML3 interactions | 1.87e-04 | 20 | 114 | 3 | int:MAML3 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 2.41e-09 | 57 | 71 | 7 | 1179 | |
| GeneFamily | PDZ domain containing|Crumbs complex | 5.38e-04 | 9 | 71 | 2 | 1223 | |
| GeneFamily | Low density lipoprotein receptors | 1.15e-03 | 13 | 71 | 2 | 634 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | NID2 FBLN7 LAMB4 VWF CRIM1 SSPOP SVEP1 CCN6 SLIT2 FBN2 IGFALS SLIT1 SLIT3 LTBP1 FBN3 OTOG | 7.06e-16 | 196 | 119 | 16 | M3008 |
| Coexpression | NABA_CORE_MATRISOME | NID2 FBLN7 LAMB4 VWF COL16A1 CRIM1 SSPOP SVEP1 CCN6 SLIT2 FBN2 IGFALS SLIT1 SLIT3 LTBP1 FBN3 OTOG | 8.62e-15 | 275 | 119 | 17 | M5884 |
| Coexpression | NABA_MATRISOME | PAPPA2 NID2 FBLN7 LAMB4 TMPRSS15 VWF COL16A1 CRIM1 ADAM21 MUC5B SSPOP IL23A SVEP1 MEP1A CCN6 SLIT2 FBN2 IGFALS ADAMTSL5 FRZB SLIT1 SLIT3 SCUBE3 CCL2 LTBP1 FBN3 OTOG | 9.46e-14 | 1026 | 119 | 27 | M5889 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | NID2 FBLN7 VWF CRIM1 SSPOP SVEP1 CCN6 SLIT2 FBN2 IGFALS SLIT1 SLIT3 LTBP1 OTOG | 2.23e-13 | 191 | 119 | 14 | MM17059 |
| Coexpression | NABA_CORE_MATRISOME | NID2 FBLN7 VWF COL16A1 CRIM1 SSPOP SVEP1 CCN6 SLIT2 FBN2 IGFALS SLIT1 SLIT3 LTBP1 OTOG | 1.68e-12 | 270 | 119 | 15 | MM17057 |
| Coexpression | NABA_MATRISOME | PAPPA2 NID2 FBLN7 TMPRSS15 VWF COL16A1 CRIM1 ADAM21 MUC5B SSPOP IL23A SVEP1 MEP1A CCN6 SLIT2 FBN2 IGFALS ADAMTSL5 FRZB SLIT1 SLIT3 SCUBE3 CCL2 LTBP1 OTOG | 3.30e-12 | 1008 | 119 | 25 | MM17056 |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 7.05e-07 | 16 | 119 | 4 | MM1296 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 7.05e-07 | 16 | 119 | 4 | M2207 | |
| Coexpression | HALLMARK_WNT_BETA_CATENIN_SIGNALING | 1.32e-06 | 42 | 119 | 5 | M5895 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 3.13e-06 | 261 | 119 | 9 | M1834 | |
| Coexpression | FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON | 1.11e-05 | 166 | 119 | 7 | M39026 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | FBLN7 COL16A1 SVEP1 BNC1 SLIT2 TENM3 JAG1 SLIT3 PKD1 LRP1 RECK | 1.21e-05 | 479 | 119 | 11 | M2573 |
| Coexpression | MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN | 1.24e-05 | 235 | 119 | 8 | M2256 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | FBLN7 COL16A1 SVEP1 BNC1 SLIT2 TENM3 JAG1 SLIT3 PKD1 LRP1 RECK | 1.31e-05 | 483 | 119 | 11 | MM1082 |
| Coexpression | VALK_AML_CLUSTER_10 | 1.49e-05 | 33 | 119 | 4 | M18784 | |
| Coexpression | CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE | 1.81e-05 | 179 | 119 | 7 | M39308 | |
| Coexpression | RPS14_DN.V1_UP | 2.75e-05 | 191 | 119 | 7 | M2816 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL1 | 4.40e-05 | 364 | 119 | 9 | M39057 | |
| Coexpression | KOYAMA_SEMA3B_TARGETS_DN | 4.40e-05 | 364 | 119 | 9 | M2029 | |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL | 4.49e-05 | 365 | 119 | 9 | M39018 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC_TUMOR_CELL_DERIVED | 5.92e-05 | 17 | 119 | 3 | M47995 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM | 6.19e-05 | 217 | 119 | 7 | M16407 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | THSD7A CRIM1 SSPOP LRP1B CRB1 SLIT2 PDE8B SLIT1 LRP1 HYDIN CRB2 | 6.30e-05 | 574 | 119 | 11 | M39056 |
| Coexpression | LIM_MAMMARY_LUMINAL_MATURE_DN | 7.41e-05 | 95 | 119 | 5 | MM1328 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM | 8.43e-05 | 228 | 119 | 7 | MM1014 | |
| Coexpression | TARTE_PLASMA_CELL_VS_PLASMABLAST_UP | 8.72e-05 | 398 | 119 | 9 | M4872 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP | 1.03e-04 | 163 | 119 | 6 | M12112 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_3_CELL | 1.47e-04 | 174 | 119 | 6 | M45676 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | THSD7A CRIM1 NPDC1 CSMD2 SSPOP LRP1B CEMIP JAG2 OLFM3 TENM1 ZFHX3 CSMD1 BSN PCDH1 HYDIN | 1.49e-04 | 1106 | 119 | 15 | M39071 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_RESTING_CHONDROCYTE | 1.55e-04 | 111 | 119 | 5 | M45685 | |
| Coexpression | RUAN_RESPONSE_TO_TROGLITAZONE_UP | 1.72e-04 | 24 | 119 | 3 | M1504 | |
| Coexpression | LU_TUMOR_ANGIOGENESIS_UP | 1.95e-04 | 25 | 119 | 3 | M9946 | |
| Coexpression | VALK_AML_WITH_EVI1 | 1.95e-04 | 25 | 119 | 3 | M5200 | |
| Coexpression | RUAN_RESPONSE_TO_TROGLITAZONE_UP | 1.95e-04 | 25 | 119 | 3 | MM1164 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 2.28e-04 | 268 | 119 | 7 | M45796 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC | 2.46e-04 | 27 | 119 | 3 | M47994 | |
| Coexpression | GSE3982_CTRL_VS_LPS_4H_MAC_DN | 3.03e-04 | 199 | 119 | 6 | M5368 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_45MIN_UP | 3.11e-04 | 200 | 119 | 6 | M6629 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 3.11e-04 | 200 | 119 | 6 | M5930 | |
| Coexpression | HALLMARK_APICAL_JUNCTION | 3.11e-04 | 200 | 119 | 6 | M5915 | |
| Coexpression | GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4_KO_BCELL_UP | 3.11e-04 | 200 | 119 | 6 | M9825 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | PAPPA2 NID2 FBLN7 TMPRSS15 CRIM1 APOB TMEM235 SSPOP LRP1B SVEP1 CRB1 MEP1A PRR16 SLIT2 FBN2 FRZB SLIT1 SLIT3 SPACA6 SCUBE3 CCL2 ZFHX3 CRB2 | 1.08e-08 | 1094 | 112 | 23 | ratio_EB_vs_SC_2500_K3 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 1.07e-06 | 146 | 112 | 8 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#4_top-relative-expression-ranked_500 | 6.54e-06 | 247 | 112 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500_k4 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000 | PAPPA2 FBLN7 THSD7A APOB LRP1B SVEP1 BNC1 SLIT2 ADAMTSL5 FRZB SLIT1 SLIT3 SPACA6 SCUBE3 CCL2 ZFHX3 CRB2 | 1.76e-05 | 994 | 112 | 17 | PCBC_ratio_EB_vs_SC_1000 |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 1.83e-05 | 281 | 112 | 9 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | 1.83e-05 | 281 | 112 | 9 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#4 | PAPPA2 VWF COL16A1 SLFN5 SPTBN4 ADAMTSL5 ZNF277 PDE8B SCAPER SPACA6 CCL2 MARCHF4 | 2.33e-05 | 529 | 112 | 12 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K4 |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | NID2 SVEP1 SLIT2 TENM3 JAG1 SLIT3 LRP1 CCL2 LTBP1 CSMD1 RECK | 2.38e-05 | 445 | 112 | 11 | GSM777043_500 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 2.40e-05 | 65 | 112 | 5 | gudmap_kidney_P3_CapMes_Crym_k4_200 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_2500_k-means-cluster#5 | PAPPA2 COL16A1 CRIM1 PSD3 SVEP1 STAT1 CEMIP PRR16 SLIT2 PDE8B SLIT3 LRP1 SCUBE3 MARCHF4 RECK | 2.46e-05 | 814 | 112 | 15 | JC_fibro_2500_K5 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 2.75e-05 | 165 | 112 | 7 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | THSD7A NPDC1 SVEP1 TENM3 SLIT3 AOC3 LRP1 CCL2 LTBP1 CSMD1 RECK | 3.62e-05 | 466 | 112 | 11 | GSM777050_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.95e-05 | 310 | 112 | 9 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500 | 4.00e-05 | 388 | 112 | 10 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 4.63e-05 | 122 | 112 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | PSD3 BNC1 SLIT2 FBN2 ZNF451 JAG1 FRZB SCAPER TENM1 ZFHX3 LTBP1 | 5.90e-05 | 492 | 112 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5 |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | NID2 CRIM1 PSD3 GRN SLFN5 SVEP1 STAT1 BNC1 FRZB SVIL AOC3 LRP1 CCL2 RECK | 6.05e-05 | 778 | 112 | 14 | gudmap_kidney_adult_RenalCapsule_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | 7.45e-05 | 193 | 112 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k1 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 7.52e-05 | 337 | 112 | 9 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_500 | 9.22e-05 | 429 | 112 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000_k-means-cluster#4 | 9.95e-05 | 433 | 112 | 10 | Arv_EB-LF_1000_K4 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.09e-04 | 354 | 112 | 9 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_500_k-means-cluster#3 | 1.12e-04 | 206 | 112 | 7 | JC_fibro_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | PAPPA2 VWF COL16A1 SLFN5 SPTBN4 ZNF277 PDE8B SCAPER SPACA6 CCL2 MARCHF4 | 1.14e-04 | 530 | 112 | 11 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 1.15e-04 | 207 | 112 | 7 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | THSD7A PSD3 CEMIP BNC1 PRR16 SLIT2 FBN2 ZNF451 JAG1 FRZB SCAPER TENM1 ZFHX3 LTBP1 | 1.29e-04 | 836 | 112 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_500 | 1.35e-04 | 148 | 112 | 6 | gudmap_kidney_P3_CapMes_Crym_k2_500 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#2 | PAPPA2 APOB CSMD2 SVEP1 CRB1 CEMIP MEP1A OLFM3 FRZB SLIT1 SLIT3 SCUBE3 CCL2 FBN3 CRB2 | 1.42e-04 | 951 | 112 | 15 | Arv_EB-LF_2500_K2 |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 1.49e-04 | 455 | 112 | 10 | GSM777055_500 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_500 | 1.52e-04 | 370 | 112 | 9 | gudmap_kidney_P3_CapMes_Crym_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | THSD7A PSD3 TTPAL CEMIP BNC1 PRR16 SLIT2 FBN2 ZNF451 FRZB SCAPER TENM1 ZFHX3 LTBP1 | 1.54e-04 | 850 | 112 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.75e-04 | 464 | 112 | 10 | JC_fibro_1000_K1 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000 | PAPPA2 APOB CSMD2 SVEP1 CRB1 CEMIP OLFM3 FRZB SLIT1 SLIT3 SCUBE3 PRR9 CCL2 FBN3 CRB2 | 1.99e-04 | 981 | 112 | 15 | Arv_EB-LF_1000 |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000 | PAPPA2 COL16A1 CRIM1 SLFN5 SVEP1 STAT1 CEMIP PRR16 SLIT2 ADAMTSL5 PDE8B SLIT3 LRP1 MARCHF4 RECK | 2.19e-04 | 990 | 112 | 15 | JC_fibro_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.22e-04 | 478 | 112 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k5 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_200 | 2.52e-04 | 166 | 112 | 6 | gudmap_kidney_P3_CapMes_Crym_200 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | 2.62e-04 | 398 | 112 | 9 | gudmap_kidney_P4_CapMesRenVes_Crym_500 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_500 | PAPPA2 COL16A1 CRIM1 SVEP1 CEMIP PRR16 ADAMTSL5 PDE8B SLIT3 RECK | 2.88e-04 | 494 | 112 | 10 | JC_fibro_500 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_200 | 3.34e-04 | 175 | 112 | 6 | gudmap_kidney_P4_CapMesRenVes_Crym_200 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500 | 3.75e-04 | 418 | 112 | 9 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_500 | 4.09e-04 | 423 | 112 | 9 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#1 | 4.13e-04 | 336 | 112 | 8 | ratio_EB_vs_SC_1000_K1 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.18e-04 | 265 | 112 | 7 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000 | NID2 FLNB STAB2 THSD7A RASA3 SLFN5 SCARB1 JAG1 SVIL CCL2 PCDH1 NOTCH1 NOTCH4 | 5.25e-04 | 847 | 112 | 13 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_1000 |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | FBLN7 SSPOP LRP1B FBN2 OLFM3 ADAMTSL5 SVIL SLIT1 SLIT3 SCUBE3 DKK4 UNC80 CRB2 | 5.31e-04 | 848 | 112 | 13 | ratio_ECTO_vs_SC_2500_K3 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | PAPPA2 RASA3 PSD3 SVEP1 SLIT2 FBN2 TENM3 ZNF277 PDE8B LRP1 PHF14 LTBP1 | 5.36e-04 | 740 | 112 | 12 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.42e-04 | 267 | 112 | 7 | gudmap_developingKidney_e12.5_renal vesicle_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | 6.08e-04 | 447 | 112 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 7.11e-04 | 457 | 112 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#1 | PAPPA2 COL16A1 SLFN5 SPTBN4 PRR16 ADAMTSL5 ZNF277 PDE8B SCAPER SPACA6 CCL2 MARCHF4 RECK | 7.33e-04 | 878 | 112 | 13 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K1 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | PAPPA2 PSD3 SVEP1 SLIT2 FBN2 TENM3 SCARB1 JAG1 FRZB SVIL LRP1 RECK | 7.43e-04 | 768 | 112 | 12 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#3 | 7.51e-04 | 204 | 112 | 6 | ratio_EB_vs_SC_500_K3 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#2_top-relative-expression-ranked_1000 | 7.63e-04 | 369 | 112 | 8 | gudmap_kidney_adult_RenalCapsule_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#1 | 7.68e-04 | 462 | 112 | 9 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K1 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | RASA3 PSD3 SVEP1 BNC1 SLIT2 FBN2 TENM3 SCARB1 JAG1 SVIL LRP1 RECK | 8.22e-04 | 777 | 112 | 12 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | NID2 FLNB STAB2 THSD7A SLFN5 SCARB1 CCL2 PCDH1 NOTCH1 NOTCH4 | 8.76e-04 | 570 | 112 | 10 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_k3_1000 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | PAPPA2 NID2 CRIM1 NSD2 MEP1A SLIT2 FBN2 TENM3 JAG1 SCUBE3 LTBP1 NOTCH1 | 8.79e-04 | 783 | 112 | 12 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#3_top-relative-expression-ranked_1000 | 9.35e-04 | 293 | 112 | 7 | gudmap_kidney_P0_JuxtaGlom_Ren1_k3_1000 | |
| CoexpressionAtlas | Myeloid Cells, MF.II-480hi.PC, F4/80hi CD115hi CD11b+ MHC II- CD11c-, Peritoneal Cavity, avg-3 | 1.12e-03 | 86 | 112 | 4 | GSM605850_100 | |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_k-means-cluster#2_top-relative-expression-ranked_500 | 1.13e-03 | 148 | 112 | 5 | gudmap_developingKidney_e12.5_renal vesicle_500_k2 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 1.13e-03 | 148 | 112 | 5 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500 | 1.28e-03 | 497 | 112 | 9 | PCBC_EB_fibroblast_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.32e-03 | 311 | 112 | 7 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k3_1000 | |
| CoexpressionAtlas | Mesoderm Day 30-reprogram_OSKM - NLT_vs_Mesoderm Day 30-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 1.35e-03 | 501 | 112 | 9 | PCBC_ratio_MESO-30_from-OSKM - NLT_vs_MESO-30_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | MESO-30 fibroblast_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05 | 1.35e-03 | 501 | 112 | 9 | PCBC_ratio_MESO-30 fibroblast_vs_MESO-30 blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 30-method_plasmid_vs_Mesoderm Day 30-method_NA-Confounder_removed-fold2.0_adjp0.05 | 1.35e-03 | 501 | 112 | 9 | PCBC_ratio_MESO-30_from-plasmid_vs_MESO-30_from-ESC_cfr-2X-p05 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TMPRSS15 STAB2 ZAN MUC5B APOB SSPOP LRP1B FBN2 TENM1 CSMD1 HYDIN UNC80 OTOG | 3.12e-15 | 184 | 119 | 13 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TMPRSS15 STAB2 ZAN MUC5B APOB SSPOP LRP1B FBN2 TENM1 CSMD1 HYDIN UNC80 OTOG | 3.12e-15 | 184 | 119 | 13 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TMPRSS15 STAB2 ZAN MUC5B APOB SSPOP LRP1B FBN2 TENM1 CSMD1 HYDIN UNC80 OTOG | 3.12e-15 | 184 | 119 | 13 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-10 | 190 | 119 | 10 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-10 | 191 | 119 | 10 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 1.25e-10 | 194 | 119 | 10 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.60e-10 | 199 | 119 | 10 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.60e-10 | 199 | 119 | 10 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.60e-10 | 199 | 119 | 10 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.90e-09 | 186 | 119 | 9 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.19e-09 | 189 | 119 | 9 | c45734970036e6d28d5e3fe7c9458fae38a3f624 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-09 | 190 | 119 | 9 | 38a815abf0ac5cac6071737cadc54a514f62d37d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.29e-09 | 190 | 119 | 9 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-09 | 190 | 119 | 9 | bb1476b44dd49e1dd52a636a91c4600b6d4fbe2e | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-09 | 190 | 119 | 9 | d180205c70b5ca9bc5a01a2e6cb42fcebc7f630d | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.51e-09 | 192 | 119 | 9 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-B_(Artery)|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.75e-09 | 194 | 119 | 9 | f8a59bd4609d147d8a706bf606e9e8173c9992a3 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-B_(Artery)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.75e-09 | 194 | 119 | 9 | 04b1acc2e879feafb43f75435281c5acd8d23be2 | |
| ToppCell | (6)_Endothelial-B_(Artery)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.75e-09 | 194 | 119 | 9 | 0cf4e67d4024652794b5bfdd4a71a7d98900b4c8 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.88e-09 | 195 | 119 | 9 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | COPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class | 3.01e-09 | 196 | 119 | 9 | af206bb5bbb8b604a6212acd79878bcc3d326cec | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.14e-09 | 197 | 119 | 9 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 3.14e-09 | 197 | 119 | 9 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 3.14e-09 | 197 | 119 | 9 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 3.44e-09 | 199 | 119 | 9 | 211c3a08f2d484ab7a3368006767289088f0d957 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.44e-09 | 199 | 119 | 9 | 6a2943a23fdd2ec814662db7c21a0d6804a6cbbc | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type | 3.44e-09 | 199 | 119 | 9 | 1a0add79f4e34078b3475eb11c85a4234bda197c | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 3.44e-09 | 199 | 119 | 9 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | wk_20-22-Mesenchymal-Chondrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.02e-08 | 171 | 119 | 8 | d2938639e9a7c349e5a6ec61724222f9d127c89f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-08 | 175 | 119 | 8 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.65e-08 | 177 | 119 | 8 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.65e-08 | 177 | 119 | 8 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.89e-08 | 179 | 119 | 8 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-OMD+_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.89e-08 | 179 | 119 | 8 | 8c9ed247e1c4d655b81ce2f24a9936a7cade718a | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.43e-08 | 183 | 119 | 8 | 3427f3cbe6ea81709750e7dd3ff378f03ae65eab | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.58e-08 | 184 | 119 | 8 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.89e-08 | 186 | 119 | 8 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.23e-08 | 188 | 119 | 8 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.23e-08 | 188 | 119 | 8 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.40e-08 | 189 | 119 | 8 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.40e-08 | 189 | 119 | 8 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 4.59e-08 | 190 | 119 | 8 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.78e-08 | 191 | 119 | 8 | 50601ef0a5a8f2c2120922989e08e85bf2d9b4ab | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.78e-08 | 191 | 119 | 8 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.78e-08 | 191 | 119 | 8 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.97e-08 | 192 | 119 | 8 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.97e-08 | 192 | 119 | 8 | a7d08416f07f29ad920168a3b52ddf992f263bf4 | |
| ToppCell | IPF-Endothelial-VE_Arterial|IPF / Disease state, Lineage and Cell class | 5.18e-08 | 193 | 119 | 8 | bf83b1fe9d38408f30eee4eb634341c04ef82791 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.18e-08 | 193 | 119 | 8 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | IPF-Endothelial-VE_Arterial|World / Disease state, Lineage and Cell class | 5.18e-08 | 193 | 119 | 8 | 70a9aadda83a97e06e9bc2d1327ce60dd3c58767 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.61e-08 | 195 | 119 | 8 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.61e-08 | 195 | 119 | 8 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | facs-Heart-RA-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-08 | 195 | 119 | 8 | 30c75761079fa1e1a3b84d23c88a222f459d5ce5 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 5.61e-08 | 195 | 119 | 8 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.83e-08 | 196 | 119 | 8 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 6.06e-08 | 197 | 119 | 8 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Endothelial-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 6.06e-08 | 197 | 119 | 8 | f969685dee212f33a6f09e54c0cd1fd24ffef546 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.06e-08 | 197 | 119 | 8 | ae0435f4b4a9cdedb1c201fc56921048390097bf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.06e-08 | 197 | 119 | 8 | 37f6b6f2809b952382eaebb642b0aad6371f4251 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.06e-08 | 197 | 119 | 8 | 1a137af40697137bb9d2b5caf2b1ffda55f04461 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.06e-08 | 197 | 119 | 8 | 4cf4e9553397cd8dee883dbec24f41bec41aff99 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.06e-08 | 197 | 119 | 8 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.06e-08 | 197 | 119 | 8 | 96d63a8d00583e2aa0a38412e2ae27e23f399493 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.31e-08 | 198 | 119 | 8 | 5e781583908c4ee107d986904a646a7c6b8e3591 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.31e-08 | 198 | 119 | 8 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Tracheal-10x5prime-Stromal-Chondrocytic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.31e-08 | 198 | 119 | 8 | c72ef2ddcbb6dacbed4c6200d89e17d57314dcdc | |
| ToppCell | COVID-19-kidney-Fibroblast-2|kidney / Disease (COVID-19 only), tissue and cell type | 6.31e-08 | 198 | 119 | 8 | ca26ca460856b1faaa3e83766da6abdf63af2b51 | |
| ToppCell | Tracheal-10x5prime-Stromal-Chondrocytic-Chondrocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.31e-08 | 198 | 119 | 8 | 55f013e9e6587d9ece59751fa131b1d22d6cceea | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.56e-08 | 199 | 119 | 8 | ba586690f88fd051f449753bfe7603a2cb431782 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.56e-08 | 199 | 119 | 8 | 38ed3bc7daa993d9edcf3e7834597ebb06dd24f8 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.56e-08 | 199 | 119 | 8 | 06a7d874ff7c4616577f6e59d3118717a8c47c00 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.56e-08 | 199 | 119 | 8 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Mesothelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 6.56e-08 | 199 | 119 | 8 | ca970114b5aef4518ce580897a62ac88688b2671 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.56e-08 | 199 | 119 | 8 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.56e-08 | 199 | 119 | 8 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.56e-08 | 199 | 119 | 8 | abd6117f8a3d7e798d8471c16d97b34aaf50fc9c | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.81e-08 | 200 | 119 | 8 | ac6b8bc9998d303f788511b8f111e682ea9f3df8 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 6.81e-08 | 200 | 119 | 8 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.81e-08 | 200 | 119 | 8 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.81e-08 | 200 | 119 | 8 | 27507c4b41d45c7cc50e4993169c0302be22ee34 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.81e-08 | 200 | 119 | 8 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 6.81e-08 | 200 | 119 | 8 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 6.81e-08 | 200 | 119 | 8 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | tumor_Lung-Fibroblasts|tumor_Lung / Location, Cell class and cell subclass | 6.81e-08 | 200 | 119 | 8 | 073a68b5ce232203ffee86342cba2a00d907e119 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.81e-08 | 200 | 119 | 8 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Endothelial-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 6.81e-08 | 200 | 119 | 8 | b65fb8d378abd91cdabf5faac5f4b90d527f8c44 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.81e-08 | 200 | 119 | 8 | 2cb6e35add34b9dc564ebcf5d3cbc761325ca9f4 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.81e-08 | 200 | 119 | 8 | ac8a5d71acd4d401995babd233f0d3738e8ad2a5 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.81e-08 | 200 | 119 | 8 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-07 | 160 | 119 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-07 | 160 | 119 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.64e-07 | 161 | 119 | 7 | 048b7dc00746987a24bf870d4d278c4183eb04a2 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D122|Adult / Lineage, Cell type, age group and donor | 3.52e-07 | 168 | 119 | 7 | 8c3e1e45b422813bcdfa4273b1167db649a312f5 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.81e-07 | 170 | 119 | 7 | 55fe16d98ea284d05fb899888e4569c685644c7b | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.13e-07 | 172 | 119 | 7 | c84cab89c97d647b8a256fd08e33d9102810febd | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D175|Adult / Lineage, Cell type, age group and donor | 4.64e-07 | 175 | 119 | 7 | 0a65ddfa8c2e8efb5b5338cf07661cb78157a23c | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-OMD+_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.82e-07 | 176 | 119 | 7 | 52af8f717dbd3b59eeb868b8b7b256a8f3e57d7a | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.20e-07 | 178 | 119 | 7 | 8591a40fced747ac16b3e8ebc7a22dfb3ad76da2 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.82e-07 | 181 | 119 | 7 | 4d7793026373cbcf04b15c77f95f1025d07d4c00 | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 6.74e-07 | 185 | 119 | 7 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| Computational | Metal / Ca ion binding. | 4.44e-05 | 133 | 77 | 7 | MODULE_324 | |
| Computational | Adhesion molecules. | 6.44e-05 | 141 | 77 | 7 | MODULE_122 | |
| Computational | ECM and collagens. | 1.98e-04 | 225 | 77 | 8 | MODULE_47 | |
| Computational | Genes in the cancer module 27. | 2.08e-04 | 355 | 77 | 10 | MODULE_27 | |
| Computational | Ovary genes. | 2.78e-04 | 368 | 77 | 10 | MODULE_1 | |
| Computational | Neighborhood of TIMP2 | 3.16e-04 | 46 | 77 | 4 | GNF2_TIMP2 | |
| Computational | Neighborhood of KISS1 | 4.04e-04 | 49 | 77 | 4 | GNF2_KISS1 | |
| Computational | Placenta genes. | 4.29e-04 | 463 | 77 | 11 | MODULE_38 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.37e-04 | 50 | 77 | 4 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_PDAC_RELATED_3 | |
| Computational | Membranal receptors. | 1.07e-03 | 517 | 77 | 11 | MODULE_64 | |
| Drug | Rilmenidine hemifumarate [54187-04-1]; Down 200; 8.4uM; HL60; HT_HG-U133A | 8.36e-07 | 197 | 117 | 9 | 3133_DN | |
| Drug | Foropafant | 1.31e-06 | 5 | 117 | 3 | ctd:C071317 | |
| Drug | LMWH | SELP PAPPA2 NID2 LAMB4 VWF COL16A1 AZU1 APOB ITGAM SLIT2 ADAMTSL5 LRP1 CCL2 MUSK | 7.98e-06 | 663 | 117 | 14 | CID000000772 |
| Disease | pulse pressure measurement | PAPPA2 FLNB TRAF1 CRIM1 SSPOP CDPF1 SVEP1 SPTBN4 PRR16 FBN2 OLFM3 JAG1 SLIT1 SLIT3 PKD1 LRP1 ZFHX3 LTBP1 CNOT1 HYDIN MUSK | 6.66e-08 | 1392 | 113 | 21 | EFO_0005763 |
| Disease | descending aortic diameter | 1.16e-06 | 88 | 113 | 6 | EFO_0021788 | |
| Disease | body weight | PAPPA2 NID2 COL16A1 CRIM1 RMI2 SPATA31C2 LRP1B SPATA31C1 CRB1 PRR16 SLIT2 FBN2 SLIT1 SLIT3 PKD1 ZFHX3 LTBP1 RMC1 | 1.44e-06 | 1261 | 113 | 18 | EFO_0004338 |
| Disease | Carcinoma, Pancreatic Ductal | 2.04e-06 | 24 | 113 | 4 | C0887833 | |
| Disease | Schizophrenia | PSD3 GRN IDE CSMD2 ITGAM JAG2 PTPRA JAG1 SLIT3 LRP1 CCL2 CSMD1 DKK4 NOTCH4 | 7.35e-06 | 883 | 113 | 14 | C0036341 |
| Disease | response to docetaxel trihydrate | 1.45e-05 | 2 | 113 | 2 | GO_1902519 | |
| Disease | neutrophil count | SELP PAPPA2 FLNB FBLN7 PSD3 TMEM235 JAG2 OLFM3 PTPRA PKD1 IQSEC1 SCUBE3 PRR9 RMC1 HYDIN MUSK NOTCH4 | 2.03e-05 | 1382 | 113 | 17 | EFO_0004833 |
| Disease | sexual dimorphism measurement | PAPPA2 ANKRD31 CRIM1 SPATA31C2 APOB SPATA31C1 SCARB1 SLIT1 SLIT3 PKD1 SCUBE3 ZFHX3 LTBP1 BSN RMC1 | 2.15e-05 | 1106 | 113 | 15 | EFO_0021796 |
| Disease | amygdala volume change measurement | 2.95e-05 | 16 | 113 | 3 | EFO_0021490 | |
| Disease | body surface area | PAPPA2 COL16A1 CRIM1 SPATA31C2 SPATA31C1 CDPF1 FBN2 SLIT1 SLIT3 ZFHX3 LTBP1 | 3.77e-05 | 643 | 113 | 11 | EFO_0022196 |
| Disease | lung adenocarcinoma (is_implicated_in) | 3.78e-05 | 49 | 113 | 4 | DOID:3910 (is_implicated_in) | |
| Disease | pulmonary fibrosis (biomarker_via_orthology) | 4.10e-05 | 50 | 113 | 4 | DOID:3770 (biomarker_via_orthology) | |
| Disease | connective tissue disease (implicated_via_orthology) | 4.35e-05 | 3 | 113 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | obesity (is_marker_for) | 4.45e-05 | 101 | 113 | 5 | DOID:9970 (is_marker_for) | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 5.17e-05 | 53 | 113 | 4 | C4707243 | |
| Disease | response to lithium ion | 6.42e-05 | 56 | 113 | 4 | GO_0010226 | |
| Disease | psoriasis | 9.00e-05 | 273 | 113 | 7 | EFO_0000676 | |
| Disease | beta-aminoisobutyric acid measurement | 1.04e-04 | 24 | 113 | 3 | EFO_0010464 | |
| Disease | blood tin measurement | 1.18e-04 | 25 | 113 | 3 | EFO_0021530 | |
| Disease | pallidum volume change measurement, age at assessment | 1.18e-04 | 25 | 113 | 3 | EFO_0008007, EFO_0021494 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 1.37e-04 | 128 | 113 | 5 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 1.37e-04 | 128 | 113 | 5 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 1.37e-04 | 128 | 113 | 5 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 1.37e-04 | 128 | 113 | 5 | C1306837 | |
| Disease | Renal Cell Carcinoma | 1.37e-04 | 128 | 113 | 5 | C0007134 | |
| Disease | arecaidine measurement | 1.44e-04 | 5 | 113 | 2 | EFO_0801112 | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 1.46e-04 | 69 | 113 | 4 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | serum IgG glycosylation measurement | 1.88e-04 | 523 | 113 | 9 | EFO_0005193 | |
| Disease | dietary heme iron intake measurement, type 2 diabetes mellitus | 2.16e-04 | 6 | 113 | 2 | EFO_0008355, MONDO_0005148 | |
| Disease | renal overload-type gout | 2.16e-04 | 6 | 113 | 2 | EFO_0021525 | |
| Disease | familial combined hyperlipidemia (is_marker_for) | 2.16e-04 | 6 | 113 | 2 | DOID:13809 (is_marker_for) | |
| Disease | Malignant neoplasm of breast | NID2 FLNB ERBB2 VWF NSD2 STAT1 JAG2 ZNF277 JAG1 TENM1 EHMT1 NOTCH1 NOTCH4 | 2.43e-04 | 1074 | 113 | 13 | C0006142 |
| Disease | Glioblastoma | 2.46e-04 | 79 | 113 | 4 | C0017636 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 2.69e-04 | 148 | 113 | 5 | C0279702 | |
| Disease | serum metabolite measurement | LAMB4 CRIM1 PSD3 APOB TMEM235 ITGAM SLIT2 TENM3 SCARB1 ZFHX3 CSMD1 MUSK | 2.77e-04 | 945 | 113 | 12 | EFO_0005653 |
| Disease | level of Phosphatidylcholine (16:0_22:6) in blood serum | 3.01e-04 | 7 | 113 | 2 | OBA_2045080 | |
| Disease | Giant Cell Glioblastoma | 3.11e-04 | 84 | 113 | 4 | C0334588 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 3.25e-04 | 239 | 113 | 6 | EFO_0008317, EFO_0020945 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 3.33e-04 | 447 | 113 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 3.40e-04 | 86 | 113 | 4 | EFO_0008595, EFO_0020945 | |
| Disease | liver fibrosis measurement | 3.40e-04 | 86 | 113 | 4 | EFO_0010576 | |
| Disease | cortical thickness | FLNB FBLN7 CRIM1 STAT1 JAG2 BNC1 SLIT2 FBN2 JAG1 PKD1 LRP1 MUSK CRB2 | 3.42e-04 | 1113 | 113 | 13 | EFO_0004840 |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 3.54e-04 | 157 | 113 | 5 | DOID:224 (biomarker_via_orthology) | |
| Disease | Cardiovascular Diseases | 3.56e-04 | 36 | 113 | 3 | C0007222 | |
| Disease | human immunodeficiency virus infectious disease (is_marker_for) | 3.56e-04 | 36 | 113 | 3 | DOID:526 (is_marker_for) | |
| Disease | sex interaction measurement, Crohn's disease | 3.86e-04 | 37 | 113 | 3 | EFO_0000384, EFO_0008343 | |
| Disease | eosinophil cationic protein measurement | 4.01e-04 | 8 | 113 | 2 | EFO_0010913 | |
| Disease | bipolar II disorder | 4.01e-04 | 8 | 113 | 2 | EFO_0009964 | |
| Disease | total cholesterol measurement, response to escitalopram, response to citalopram | 4.01e-04 | 8 | 113 | 2 | EFO_0004574, EFO_0006329, EFO_0007871 | |
| Disease | familial hyperlipidemia (is_implicated_in) | 4.01e-04 | 8 | 113 | 2 | DOID:1168 (is_implicated_in) | |
| Disease | free cholesterol change measurement, high density lipoprotein cholesterol measurement | 4.01e-04 | 8 | 113 | 2 | EFO_0004612, EFO_0020905 | |
| Disease | sporadic amyotrophic lateral sclerosis, survival time | 4.01e-04 | 8 | 113 | 2 | EFO_0000714, EFO_0001357 | |
| Disease | diastolic blood pressure, self reported educational attainment | 4.01e-04 | 8 | 113 | 2 | EFO_0004784, EFO_0006336 | |
| Disease | migraine disorder | 4.61e-04 | 357 | 113 | 7 | MONDO_0005277 | |
| Disease | hemangiopericytoma (is_marker_for) | 5.14e-04 | 9 | 113 | 2 | DOID:264 (is_marker_for) | |
| Disease | substance abuse, antisocial behaviour measurement | 5.14e-04 | 9 | 113 | 2 | EFO_0007052, MONDO_0002491 | |
| Disease | longitudinal alcohol consumption measurement | 5.14e-04 | 9 | 113 | 2 | EFO_0007645 | |
| Disease | colitis (biomarker_via_orthology) | 5.63e-04 | 42 | 113 | 3 | DOID:0060180 (biomarker_via_orthology) | |
| Disease | asthma | 6.33e-04 | 751 | 113 | 10 | MONDO_0004979 | |
| Disease | Short Stature, CTCAE | 6.41e-04 | 10 | 113 | 2 | C2919142 | |
| Disease | Short stature | 6.41e-04 | 10 | 113 | 2 | C0349588 | |
| Disease | acute necrotizing pancreatitis (implicated_via_orthology) | 6.41e-04 | 10 | 113 | 2 | DOID:0080998 (implicated_via_orthology) | |
| Disease | nephrogenic diabetes insipidus (implicated_via_orthology) | 6.41e-04 | 10 | 113 | 2 | DOID:12387 (implicated_via_orthology) | |
| Disease | cardiovascular system disease (is_marker_for) | 6.41e-04 | 10 | 113 | 2 | DOID:1287 (is_marker_for) | |
| Disease | response to carboplatin, response to antineoplastic agent | 6.41e-04 | 10 | 113 | 2 | GO_0097327, GO_0097328 | |
| Disease | leptin measurement, sex interaction measurement | 6.41e-04 | 10 | 113 | 2 | EFO_0005000, EFO_0008343 | |
| Disease | diabetic retinopathy (biomarker_via_orthology) | 6.90e-04 | 45 | 113 | 3 | DOID:8947 (biomarker_via_orthology) | |
| Disease | motor function measurement | 7.82e-04 | 11 | 113 | 2 | EFO_0010749 | |
| Disease | phosphatidylcholine measurement | 8.06e-04 | 284 | 113 | 6 | EFO_0010226 | |
| Disease | birth weight, pelvic organ prolapse | 8.86e-04 | 49 | 113 | 3 | EFO_0004344, EFO_0004710 | |
| Disease | Glioblastoma Multiforme | 8.91e-04 | 111 | 113 | 4 | C1621958 | |
| Disease | congenital diaphragmatic hernia (implicated_via_orthology) | 9.36e-04 | 12 | 113 | 2 | DOID:3827 (implicated_via_orthology) | |
| Disease | metabolite measurement, body weight gain | 9.36e-04 | 12 | 113 | 2 | EFO_0004566, EFO_0004725 | |
| Disease | dementia (is_implicated_in) | 9.36e-04 | 12 | 113 | 2 | DOID:1307 (is_implicated_in) | |
| Disease | autistic disorder (is_marker_for) | 9.36e-04 | 12 | 113 | 2 | DOID:12849 (is_marker_for) | |
| Disease | polyunsaturated fatty acids to total fatty acids percentage | 9.40e-04 | 50 | 113 | 3 | EFO_0022303 | |
| Disease | factor VIII measurement, coronary artery disease | 9.52e-04 | 113 | 113 | 4 | EFO_0001645, EFO_0004630 | |
| Disease | myeloid white cell count | 9.55e-04 | 937 | 113 | 11 | EFO_0007988 | |
| Disease | total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement | 9.96e-04 | 51 | 113 | 3 | EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928 | |
| Disease | antihyperlipidemic drug use measurement | 1.02e-03 | 115 | 113 | 4 | EFO_0803367 | |
| Disease | egg allergy measurement, parental genotype effect measurement | 1.10e-03 | 13 | 113 | 2 | EFO_0005939, EFO_0007018 | |
| Disease | intracranial aneurysm (biomarker_via_orthology) | 1.10e-03 | 13 | 113 | 2 | DOID:10941 (biomarker_via_orthology) | |
| Disease | Connective Tissue Diseases | 1.10e-03 | 13 | 113 | 2 | C0009782 | |
| Disease | intermediate coronary syndrome (is_marker_for) | 1.10e-03 | 13 | 113 | 2 | DOID:8805 (is_marker_for) | |
| Disease | gallbladder cancer (is_implicated_in) | 1.10e-03 | 13 | 113 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | response to cisplatin, platinum measurement | 1.11e-03 | 53 | 113 | 3 | EFO_0010154, GO_0072718 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 1.12e-03 | 118 | 113 | 4 | EFO_0001645, EFO_0004629 | |
| Disease | anti-basement membrane glomerulonephritis (implicated_via_orthology) | 1.28e-03 | 14 | 113 | 2 | DOID:4780 (implicated_via_orthology) | |
| Disease | glycodeoxycholate measurement | 1.28e-03 | 14 | 113 | 2 | EFO_0010493 | |
| Disease | free cholesterol to total lipids in large HDL percentage | 1.31e-03 | 56 | 113 | 3 | EFO_0022279 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 1.38e-03 | 57 | 113 | 3 | DOID:10652 (implicated_via_orthology) | |
| Disease | obesity (implicated_via_orthology) | 1.45e-03 | 215 | 113 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | level of Phosphatidylcholine (O-18:1_20:4) in blood serum | 1.48e-03 | 15 | 113 | 2 | OBA_2045131 | |
| Disease | Insulin Resistance | 1.60e-03 | 60 | 113 | 3 | C0021655 | |
| Disease | Insulin Sensitivity | 1.60e-03 | 60 | 113 | 3 | C0920563 | |
| Disease | free cholesterol to total lipids in medium HDL percentage | 1.60e-03 | 60 | 113 | 3 | EFO_0022282 | |
| Disease | free cholesterol in very large VLDL measurement | 1.67e-03 | 61 | 113 | 3 | EFO_0022274 | |
| Disease | proliferative diabetic retinopathy (is_marker_for) | 1.68e-03 | 16 | 113 | 2 | DOID:13207 (is_marker_for) | |
| Disease | phosphatidylcholine 38:6 measurement | 1.68e-03 | 16 | 113 | 2 | EFO_0010388 | |
| Disease | methylcobalamin deficiency type cblE, brain serotonin transporter measurement | 1.68e-03 | 16 | 113 | 2 | EFO_0004569, MONDO_0009354 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ECQPQNGSVTCFGPE | 566 | P04626 | |
| LQFEGSLPTCEAQCP | 2306 | Q96PZ7 | |
| ECLVINCGDPGIPAN | 2946 | Q7Z408 | |
| CRPPIDCGVDNFQGD | 316 | Q9UKJ8 | |
| IPGVPGLDNCAQCFL | 981 | Q07092 | |
| VGAIQCPDSQFECPD | 121 | P28799 | |
| PFQVEKDQCLNCPDA | 296 | Q01954 | |
| FVQAICEGDDCQPPA | 561 | P35858 | |
| CLPCVRENINAFPQE | 86 | Q6NVV7 | |
| DPVNCINGVCINTPG | 1451 | Q75N90 | |
| CPQDFELNPSGVGCV | 1471 | Q75N90 | |
| ESPCQQNADCINIPG | 1771 | Q75N90 | |
| DPCELCPQEGSAAFQ | 2051 | Q75N90 | |
| CPQEGSAAFQELCPF | 2056 | Q75N90 | |
| AEEFQVLPCRSCAPN | 451 | Q8WUJ3 | |
| AGACEVNPLACLPQA | 731 | Q16853 | |
| CEQPLGLECRAQAQP | 4166 | Q9HC84 | |
| CVQTACLTPDGQPVQ | 5586 | Q9HC84 | |
| LPQECPVGAQATCGQ | 61 | Q02833 | |
| IVECQGLPIVNGQCD | 151 | Q14644 | |
| EQDLQLCVGGCPPSQ | 311 | Q6ZVN8 | |
| LPCNCADQFVPVCGQ | 631 | O95980 | |
| SVPQQYQPCLPEVAC | 1791 | Q8N7Z5 | |
| VDECVGLQPVCPQGT | 271 | Q53RD9 | |
| GQQQFVPDLDCPFLC | 251 | Q5VTA0 | |
| GPRCEIDVNECVSNP | 446 | P46531 | |
| NEFQCHPDGNCVPDL | 1056 | Q9NZR2 | |
| CLCTDGYEIQPDNPN | 2991 | Q9NZR2 | |
| AGQRCQVPTLPCEAN | 1166 | Q5IJ48 | |
| QPEALSAQCPLGQRC | 916 | Q9Y219 | |
| VPGQPGCQDINECLR | 3816 | Q07954 | |
| CICNPGVVRQFRNPD | 636 | Q6DN90 | |
| CLPEENQVFPPGRNC | 896 | P98073 | |
| QVCNLCGFNPTPHLV | 491 | Q9UPA5 | |
| PFVVQVGEACNPNAC | 441 | O75369 | |
| DINECQLQGVCPNGE | 626 | Q14766 | |
| QDINECEHPGLCGPQ | 1201 | Q14766 | |
| RECQNQLPGDPCILE | 121 | Q08174 | |
| CECNPAGKNFPENQI | 756 | O95263 | |
| FEEQCISLGPCPQGN | 831 | Q6ZU69 | |
| CHPQVCPAGEFCQNQ | 1041 | O96028 | |
| IQILFICQLPFCGPN | 156 | Q8NGP0 | |
| CGDAFQQTLIICPPA | 616 | Q9H422 | |
| VSPSCELCPNQDGIF | 381 | O94880 | |
| VPFHGAPNQCDLNCL | 126 | Q6ZMM2 | |
| CQEACPVDAIVEGPN | 156 | O00217 | |
| HACGPCLQPFQEDQQ | 61 | Q9NQX5 | |
| CLQPFQEDQQGLCVP | 66 | Q9NQX5 | |
| PQCDEQGNFLPLQCH | 961 | Q14112 | |
| PPLCGQTVCDNVELI | 496 | Q9BXP8 | |
| QEFKLCENLQGECPP | 1641 | Q9BXP8 | |
| NGQVFQPNPLFSCLC | 131 | O95389 | |
| PITLQALVQCGQPQC | 376 | P04114 | |
| VCCINDNPEPAIFQL | 2911 | Q4G0P3 | |
| CEKECQAPPNILNGQ | 406 | P20023 | |
| QAPEIFQRCDCGPGL | 186 | Q9UBT3 | |
| GLAQPDAINAPVTCC | 21 | P13500 | |
| CCTQDFVLPDGRVIP | 401 | Q9HBI6 | |
| NDVPHIQCGDGCDPQ | 66 | Q9NPF7 | |
| FGVDCRTVECPPVQQ | 251 | Q9NZV1 | |
| PLCRICFQGPEQGEL | 161 | Q9P2E8 | |
| PVCQALQCQDLPVPN | 441 | P16109 | |
| LNEKVCGDPGNVPCV | 1371 | A4D0S4 | |
| CPVVGEFPCQNDINL | 966 | P14735 | |
| VNECEVFPGVCPNGR | 956 | P35556 | |
| PNGACVDRNECLEIP | 1886 | P35556 | |
| GAQCQPVLQGFECIA | 936 | P82279 | |
| LVQCANVAPCPNIVD | 161 | O75712 | |
| PEDQCRPNNVCTGVL | 176 | P20160 | |
| QCVPCPAGTFQEREG | 651 | Q8IX30 | |
| CACFLSVQGPVDENP | 1116 | Q9BY12 | |
| AQACIPPCGLQEFAR | 121 | W5XKT8 | |
| AEAVPARGEPQQDCC | 6 | Q9H9B1 | |
| PDGRCICTVVAPEQN | 61 | Q96PB7 | |
| ENVCPALVATFVPGC | 871 | P98161 | |
| NALPACPIQATCEAA | 246 | P18433 | |
| FFCEIQPVLQLVCGD | 176 | Q96KK4 | |
| LCQLDIDYCEPNPCQ | 521 | P78504 | |
| QCQAPDTIVPVDLGC | 2461 | Q6ZRI0 | |
| QQAPPDAGFPVVCCE | 66 | Q8TEE9 | |
| GVVQACSPEPCLQAV | 106 | Q96E14 | |
| ACIGGPPNACLDQLQ | 246 | P42224 | |
| QRQQFQAPVCGFPCN | 1081 | B4DYI2 | |
| RAQGEVCQALPCPVT | 3296 | A2VEC9 | |
| VAGILQCQEVPDCPD | 3631 | A2VEC9 | |
| VLQGKEPPCFLQCFQ | 1846 | O95425 | |
| PVPALTQACQIPCQD | 891 | Q9UPZ6 | |
| NVCLPGNLPLCNFTD | 226 | Q969Y0 | |
| IPNGDICCIPNSNLD | 166 | Q569H4 | |
| PNPCQNDGICVNVKG | 676 | Q16819 | |
| PNEGFCPCLESGIQN | 316 | Q8WTV0 | |
| GGVNCETPLPVCQEQ | 651 | Q9UKZ4 | |
| NCIPEQFPTEGICAQ | 76 | P14410 | |
| VCQRIQCDIPFFGIQ | 1026 | P11215 | |
| QQRQQFQAPVCGFPC | 1086 | P0DKV0 | |
| NIPTVGIVDTNCNPC | 216 | Q9Y399 | |
| DIDECSPLPCLNNGV | 1231 | Q4LDE5 | |
| CNAIHCDSPQPIENG | 2551 | Q4LDE5 | |
| VGGPCVPAFQQCILQ | 1111 | Q9NZP6 | |
| GFLGETCQFPDPCQN | 56 | Q99466 | |
| CPPGLEGQLCEVETN | 501 | Q99466 | |
| QCLQDILAAGCPTEP | 616 | P51801 | |
| GFCDVIPPNCIQLRN | 2116 | A5YKK6 | |
| FCQPVPACDSILGQT | 301 | Q9BTX7 | |
| NPLVEQPRACACGEA | 191 | Q96EG3 | |
| QFCIPCQLHNTTPVG | 1286 | Q9BXT8 | |
| VVQQEPTCRCPPGFA | 1136 | O75094 | |
| LPQIIQCFACPNCFL | 246 | Q9Y4E5 | |
| PNPELQFICADCGVS | 286 | Q96SZ4 | |
| RFQFLLNCCEPGTIP | 1186 | Q8N2C7 | |
| ICEGQNGCIPLVDPF | 61 | A6NFC5 | |
| QLEVPVCPSGFQLSC | 2551 | P04275 | |
| CERPVQFEKANPVNC | 11 | Q96DM3 | |
| SGCLCPPLNVNEEYI | 241 | Q92765 | |
| CNLPENPLFIACGGQ | 276 | P80108 | |
| CPPQCAEPCQELFQT | 81 | Q5T870 | |
| CLSENPRNGEDQICP | 41 | Q13077 | |
| GYQPCDPQVICNRVN | 606 | Q9H254 | |
| DGQVCLPVDPCQINF | 271 | Q8WWQ8 | |
| PDAPCNNRGVCLDQY | 1966 | Q8WWQ8 | |
| CQNQPYCRGLPDPQD | 806 | Q9P273 | |
| NEPICQCLPGYQGEK | 1141 | O94813 | |
| IVNNSICPGEDPCQS | 91 | Q8TA94 | |
| IGLPDNIVNCNEFLC | 201 | Q9NRM2 | |
| QEKSQEPCLPCGENL | 536 | Q9UI33 | |
| LNPCQHEAQCVGTPD | 1051 | O75093 | |
| NCVDQGNRPVCQCLP | 1141 | O75093 | |
| PPDAQKDALGCCVVQ | 16 | Q6WRX3 | |
| CHPQEQQGVQPLTGC | 86 | Q9NYI0 | |
| ELCPGVNNQPYLCES | 26 | Q96G27 | |
| CEPANILYICENQPL | 601 | Q08AF3 | |
| PISECCGIVPQLQNI | 191 | Q6SJ96 | |
| ANLPPQLIPYQCDQC | 2521 | Q15911 | |
| NCAILINPQGPFSQC | 1741 | Q9Y493 | |
| RDGNILSCPENCPVE | 816 | O15146 |